10QSB 1 flx06q3e

0001548123-16-000596.txt : 20160516 0001548123-16-000596.hdr.sgml : 20160516 20160516163213 ACCESSION NUMBER: 0001548123-16-000596 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 39 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160516 DATE AS OF CHANGE: 20160516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLEXPOINT SENSOR SYSTEMS INC CENTRAL INDEX KEY: 0000925660 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 870620425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-24368 FILM NUMBER: 161654400 BUSINESS ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 8015685111 MAIL ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: MICROPOINT INC DATE OF NAME CHANGE: 19980424 FORMER COMPANY: FORMER CONFORMED NAME: NANOTECH CORP DATE OF NAME CHANGE: 19940620 10-Q 1 f2016flexpointq110qv4.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2016 10QSB 1 flx06q3e

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For quarterly period ended March 31, 2016

[ ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission file number: No. 0-24368

FLEXPOINT SENSOR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)


Delaware	87-0620425
(State of incorporation)	(I.R.S. Employer Identification No.)

106 West Business Park Drive, Draper, Utah 84020

(Address of principal executive offices)

801-568-5111

(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ X ] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.:


Large accelerated filer [ ]	Accelerated filer [ ]
Non-accelerated filer [ ]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.

Yes [ ] No [X]

The number of shares outstanding of the registrant’s common stock was 71,627,114 as of May 16, 2016.

TABLE OF CONTENTS

PART I: FINANCIAL INFORMATION


Item 1.	Condensed Financial Statements

	Condensed Consolidated Balance Sheets (Unaudited) at March 31, 2016 and		3
		December 31, 2015 (Audited)

	Condensed Consolidated Statements of Operations (Unaudited) for the Three		4
		Months Ended March 31, 2016 and 2015

	Condensed Consolidated Statements of Cash Flows (Unaudited) for the		5
		Three Months Ended March 31, 2016 and 2015

	Notes to Condensed Consolidated Financial Statements (Unaudited)		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		13

Item 3.	Quantitative and Qualitative Disclosure about Market Risk		17

Item 4.	Controls and Procedures		18

PART II: OTHER INFORMATION


Item 1A.	Risk Factors	18

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19

Item 6.	Exhibits	20

Signatures		21

PART I - FINANCIAL INFORMATION

ITEM 1. CONDENSED FINANCIAL STATEMENTS

The financial information set forth below with respect to our condensed consolidated financial position as of March 31, 2016, the condensed consolidated statements of operations for the three months ended March 31, 2016 and 2015, and cash flows for the three months ended March 31, 2016 and 2015 are unaudited. The information presented below for the condensed consolidated financial position as of December 31, 2015 was audited and reported as part of our annual filing of our Form 10-K, filed with Securities and Exchange Commission on April 14, 2016. The results of operations for the three months ended March 31, 2016 and 2015, respectively, are not necessarily indicative of results to be expected for any subsequent periods.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS


	March 31, 2016 (Unaudited)	December 31, 2015
ASSETS
Current Assets
Cash and cash equivalents	$ 32,779	$ 22,706
Accounts receivable, net of allowance for bad debts of $7,140 and $7,140	111,027	98,557
Notes receivable	88,721	86,806
Deposits and prepaid expenses	9,312	11,949
Total Current Assets	241,839	220,018
Long-Term Deposits	6,550	6,550
Property and Equipment, net of accumulated depreciation
of $586,394 and $586,394	-	-
Patents and Proprietary Technology, net of accumulated
amortization of $816,844 and $793,103	155,551	179,292
Goodwill	4,896,917	4,896,917
Total Assets	$ 5,300,857	$ 5,302,777

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable	$ 168,429	$ 160,437
Accounts payable - related party	3,035	322
Accrued liabilities	474,318	375,244
Convertible notes payable , net of discount of $616,077 and $763,352	342,380	45,105
Convertible notes payable - related party	40,000	40,000
Total Liabilities	1,028,162	621,108


Stockholders' Equity
Preferred stock – $0.001 par value; 1,000,000 shares authorized;
no shares issued or outstanding	-	-
Common stock – $0.001 par value; 100,000,000 shares authorized;
71,627,114 shares and 71,627,114 shares issued and outstanding	71,627	71,627
Stock subscription payable	10,958	9,958
Additional paid-in capital	28,629,112	28,569,711
Accumulated deficit	(24,439,002)	(23,969,627)
Total Stockholders' Equity	4,272,695	4,681,669
Total Liabilities and Stockholders' Equity	$ 5,300,857	$ 5,302,777

The accompanying notes are an integral part of these condensed consolidated financial statements

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)


		For the Three Months
		Ended March 31,
	2016		2015

Design, Contract and Testing Revenue		$35,165		$32,000

Operating Costs and Expenses
Amortization of patents and proprietary technology		23,741		25,585
Cost of revenue		1,344		2,827
Administrative and marketing expense		177,420		161,707
Research and development expense		80,059	66,420

Total Operating Costs and Expenses		282,564		256,539

Other Income and Expenses
Interest expense		(223,891)		(141,538)
Interest income		1,915		15
Gain on conversion of notes		-		55,661
Loss on extinguishment of debt		-		(168,286)

Net Other Income (Expense)		(221,976)		(254,148)

Net Loss		$(469,375)		$(478,687)

Basic and Diluted Loss per Common Share		$(0.01)		$(0.01)

Basic and Diluted Weighted Average Common Shares Outstanding		71,627,114		57,864,114

The accompanying notes are an integral part of these condensed consolidated financial statements

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)



	For the Three Months
	Ended March 31,
	2016	2015
Cash Flows from Operating Activities:
Net loss	$ (469,375)	$ (478,687)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock subscription for compensation	1,000	--
Stock-based compensation expense	8,401	--
Amortization of patents and proprietary technology	23,741	25,585
Amortization of discount on note payable	198,275	110,872
Loss on extinguishment of debt	--	168,286
(Gain)/loss on conversion of notes payable to common stock	--	(55,661)
Changes in operating assets and liabilities:
Accounts receivable	(12,470)	21,120
Deposits and prepaid expenses	2,637	(15)
Accounts payable	7,992	(5,876)
Accounts payable – related parties	2,713	1,561
Accrued liabilities	99,074	83,409
Net Cash Used in Operating Activities	(138,012)	(129,406)

Cash Flows from Investing Activities:
Note receivable interest income	(1,915)	--
Net Cash Used in Investing Activities	(1,915)	--
Cash Flows from Financing Activities:
Proceeds from borrowings under convertible note payable	150,000	120,000
Net Cash Provided by Financing Activities	150,000	120,000

Net Change in Cash and Cash Equivalents	10,073	(9,406)
Cash and Cash Equivalents at Beginning of Period	22,706	18,307
Cash and Cash Equivalents at End of Period	$ 32,779	$ 8,901

Supplemental Cash Flow Information:
Cash paid for income taxes	$ --	$ --
Cash paid for interest	$ --	$ --
Supplemental Disclosure on Noncash Investing and Financing Activities
Common stock issued for debt conversion	$ --	$ 305,073
Convertible notes issued and debt discount relieved in debt extinguishment	$ --	$ 1,079,453
Subscription payable to employee	$ --	$ 9,958
Recognition of discounts on convertible notes payable	$ 51,000	$ 1 ,009,048

The accompanying notes are an integral part of these condensed consolidated financial statements

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1– SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2015 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 14, 2016. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2016.

Nature of Operations – The Company is located near Salt Lake City, in Draper, Utah and is a company engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors^® flexible potentiometer technology. The Company suffered losses of $469,375 and $478,687 and used cash in operating activities of $138,012 and $129,406 during the three months ended March 31, 2016 and 2015, respectively. Through March 31, 2016, the Company had an accumulated deficit of $24,439,002. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $32,779 at March 31, 2016 and $22,706 at December 31, 2015 represent cash on deposit in various bank accounts with a financial institution.

Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates that approximate current market rates.

Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees, and are shown net of the allowance for bad debts. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured. While the Company has historically experienced very minimal bad debts it felt it prudent to create an allowance for doubtful accounts to provide for any risk associated with bad debts on current receivables.

Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such a contract additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied.

Inventories – Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method. Inventories consist of raw materials.

Property and Equipment – Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Valuation of Long-lived Assets – The carrying values of the Company’s long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company’s analysis did not indicate any impairment of assets as of March 31, 2016.

Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company’s analysis did not indicate any impairment of intangible assets as of March 31, 2016.

Research and Development – Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.

Goodwill – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in ASC 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company’s targeted market conditions, as well as relevant entity-specific events; such as a change in the market for the Company’s products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company’s assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.

Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.

Stock-Based Compensation – Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.

Basic and Diluted Earnings (loss) Per Share – Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings (loss) by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 21,720,103 shares of common stock. These common stock equivalents were not included in the computation of diluted loss as their effect would be anti-dilutive. Other convertible notes and options-related exercise prices were less than the average market price of the common stock.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Concentrations and Credit Risk - The Company has a major customer who represents a significant portion of revenue, accounts receivable and notes receivable. During the three months ended March 31, 2016, the customer represented 28% of sales and represents 84% of accounts receivable and 100% of notes receivable at March 31, 2016. The Company has a strong relationship with this customer and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies. The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer.

Recent Accounting Pronouncements - In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") 2016-02, “Leases.” This ASU requires lessees to put most leases on their balance sheets but recognize expenses in the income statement in a manner similar to current accounting treatment. This ASU changes the guidance on sale-leaseback transactions, initial direct costs and lease execution costs, and, for lessors, modifies the classification criteria and the accounting for sales-type and direct financing leases. For public business entities, this ASU is effective for annual periods beginning after December 15, 2018, and interim periods therein. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.

In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting.” This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2016, although early adoption is permitted. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.

The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

NOTE 2 – NOTES RECEIVABLE

On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the managing member of R&D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&D Products and Mr. deGreef, specifically patented applications using Bend Sensor^® technology that were filed jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor^® applications for R&D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&D belong to Flexpoint and therefore is sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&D Products.

On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $25,000 to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of 10% to be paid no later than December 31, 2015. The Company is currently evaluating actions it should take relative to this note receivable which is in default.

On April 1, 2015, the Company paid $51,157 for the assumption and assignment of a convertible promissory note receivable issued by Bend Tech, LLC (“Bend Tech”; one of the Company’s customers – see also Note 1, Concentrations and Credit Risk) and held by a third-party Bend Tech investor (“the Investor”). The note bears

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

interest at the rate of 10% per annum and had a maturity date of April 1, 2015. The agreement allows the holder, at its option, to convert the note to a 5% ownership of Bend Tech. The Company elected to take assignment of those conversion rights, reaching an agreement with the Investor to pay the principal and interest to the Investor at the due date. Bend Tech is expected to become a more significant customer of the Company as it begins its product introductions, and the Company elected to pay off the note and put itself in position to either receive the payment plus interest or convert the note into ownership of Bend Tech rather than have an outside investor make such conversion. As of the date of this report, the note is in default and the Company has not exercised its conversion option.

NOTE 3 – CONVERTIBLE NOTES PAYABLE

Convertible Notes Payable

During 2015, the Company secured additional financing to cover its ongoing operations in the amount of $590,000 by issuing various convertible notes bearing 10% annual interest (15% default interest), secured by business assets and carrying exercise prices ranging between $0.025 and $0.07 per share. Additionally during 2015, the Company issued $51,000 for a non-convertible note payable bearing 10% annual interest (15% default interest) and secured by the $51,157 note receivable held by the Company (see Note 2). During 2015, all of these notes (both convertible and non-convertible issued in 2014 and 2015) and accrued interest were either converted into common stock or extinguished and consolidated into two remaining convertible notes payable to two investors in principal amounts of $684,660 and $123,797 (with respective maturity dates of December 31, 2016 and November 30, 2016). Both notes are convertible at $0.05 per share, bear 10% annual interest rates (15% default interest) and are secured by business assets.

On January 20, 2016, the Company entered into a promissory convertible note with Capital Communications LLC for up to $300,000 which is expected to be funded in tranches of $50,000 for each of the six months thereafter. Accordingly, on January 26, 2016, February 26, 2016 and March 31, 2016, the Company received proceeds for an aggregate total of $150,000 from Capital Communications LLC. The note has an annual interest rate of 10% and is secured by the Company's business equipment. The principal amount of the note, and all accrued interest is due and payable on or before December 31, 2016 and each note has a conversion feature for restricted common shares at $0.06 per share.

At March 31, 2016, the Convertible Notes Payable principal is $998,457, the unamortized discount is $616,077 and interest accrued and unpaid is $49,217. The Company recorded interest expense of $198,275 during the three months ended March 31, 2016 as it amortized the discount charges generated by the issuance of convertible notes payable.

Convertible Note Payable Related Party

On August 8, 2011, the Company entered into a convertible note payable with a Company Director for $40,000. This note is due on December 31, 2015, bears an annual interest rate of 10% annual interest (15% default interest) and is secured by business equipment.

NOTE 4 – STOCK OPTION PLANS

On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated. This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company’s trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent. The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares. The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company’s common stock. Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees. Of the options issued, 640,000 have an option price of $0.14 per share, 900,000 have an option price of $0.15 per share, 595,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share. Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively. We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.

Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options. Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share. The options vest over three years and expire 10 years from the date of grant. The Company used the following assumptions in estimating the fair value of the options granted:

Market value at the time of issuance – Range of $0.14 to 2.07

Expected term – Range of 3.7 years to 10.0 years

Risk-free interest rate – Range of 1.60% to 4.93%

Dividend yield – 0%

Expected volatility – 200% to 424%

Weighted-average fair value - $0.16 to $2.07

As of the three months ended March 31, 2016 and the years ended December 31, 2005 through 2015, the Company recognized a total of $2,398,185 of stock-based compensation expense, leaving $37,698 in unrecognized expense as of March 31, 2016. There were 2,185,000 and 2,185,000 employee stock options outstanding at March 31, 2016 and December 31, 2015, respectively.

A summary of all employee options outstanding and exercisable under the plan as of March 31, 2016, and changes during the three months then ended is set forth below:


Options	Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

Outstanding at the beginning of period	2,185,000	$ 0.16	9.66	$ --
Granted	--	--	--	--
Expired	--	--	--	--
Forfeited	--	--	--	--
Outstanding at the end of Period	2,185,000	$ 0.16	9.41	$ --
Exercisable at the end of Period	1,755,000	$ 0.15	9.41	$ --

NOTE 5 – CAPITAL STOCK

Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. At March 31, 2016 and December 31, 2015, there were no shares of preferred stock issued or outstanding.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Common Stock – There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized. No shares of stock were issued during the three months ended March 31, 2016.

On January 12, 2015, the Board of Directors approved the conversion of $165,000 in convertible notes held by Capital Communications LLC, plus $33,023 in interest accrued and unpaid, to 2,800,000 shares of restricted common stock at an average conversion price of $0.07 per share

On January 20, 2015, the Board of Directors approved the conversion of $135,000 in convertible notes held by Empire Fund Managers, plus $23,760 in interest accrued and unpaid, to 2,650,000 shares of restricted common stock at an average conversion price of $0.06 per share.

In October 2015, the Board of Directors approved the issuance of 3,400,000 shares of restricted common stock to extinguish $330,000 in accrued liabilities arising from investor relations services, at an average price of $0.084 per share.

In November and December 2015, the Board of Directors approved the conversion of $470,000 in convertible notes to 9,400,000 shares of restricted common stock.

NOTE 6 - COMMITMENTS AND CONTINGENCIES

The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017. Either party may terminate the lease upon 90 day written notice. Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), and will pay $9,300 per month in 2016 and $9,600 per month in 2017.

In September 2005 the Company entered into a manufacturing agreement with R&D Products, LLC, a Utah limited liability company, doing business in Midvale, Utah. For the purpose of this contract, management considers R&D Products to be a related party because a controlling member of R&D Products, LLC is also a non-controlling shareholder of Flexpoint Sensor Systems, Inc. R&D Products has developed a mattress with multiple air chambers that uses the Company’s Bend Sensors^® and the Company has entered into an agreement to manufacture the Bend Sensors^® for R&D’s specific mattress use. The initial order is for 30,000 Bend Sensors^® to be used to begin manufacture of 1,000 mattresses. During 2007 and 2008 R&D Products deposited with Flexpoint the sum of $100,000 to begin work on the initial production order of 20 commercial beds. Additional revenue from this contract is dependent upon R&D Products selling either their bed technology directly or licensing their technology to a third party.

On September 11, 2008 R&D Products, LLC entered into a long-term Licensing Agreement for their bed technology with a major medical solutions provider (Licensee). The Agreement provides the Licensee the exclusive world–wide rights to R&D’s patented medical bed technology. On that same day the Company, R&D Products and the Licensee entered into a long-term joint manufacturing agreement for R&D’s medical bed technology and related products. The manufacturing agreement allows for the Company to manufacture sensors for the bed technology and related medical products through 2018 with an option to renew each year thereafter. Production schedules with specific quantities and deadlines are still being outlined. (See Note 2). At this time management is unsure the effect their litigation with R&D will have on this agreement with R&D or its Licensee.

The Company is currently evaluating actions it should take relative to the notes receivable referenced in Note 2, which are in default.

NOTE 7 – RELATED PARTY TRANSACTIONS

At March 31, 2016 and December 31, 2015, the Company had accounts payable of $3,035 and $322 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 8 - SUBSEQUENT EVENTS

On April 29, 2016 the Company drew $50,000 against a convertible promissory note for up to $300,000 from a third party, the proceeds of which will be used to fund operating expenses. The note has an annual interest rate of 10% and is secured by the Company’s equipment. The note has a conversion feature for restricted common shares at $.06 per share and a maturity date of December 31, 2016.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

In this quarterly report references to “Flexpoint", "the Company," “we,” “us,” and “our” refer to Flexpoint Sensor Systems, Inc. and its subsidiaries.

FORWARD LOOKING STATEMENTS

The U.S. Securities and Exchange Commission (“SEC”) encourages reporting companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions. This report contains these types of statements. Words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EXECUTIVE OVERVIEW

Flexpoint Sensor Systems, Inc. is an innovative technology firm specializing in developing products that feature the Company’s patented Bend Sensor^® and related technology. The Bend Sensor^® is a groundbreaking sensing solution that is revolutionizing applications in the automobile, safety, medical and industrial industries. The Bend Sensor’s single-layer, thin film construction cuts costs and mechanical bulk while introducing a range of functions and stylistic design possibilities that have never before been available in sensing technology. We currently own six patents and through our research and development, efforts are in the process of filing for more that include fully integrated products being sold and supplied to our limited customer base. We have also jointly developing additional commercially viable products, including a universal sensor that will be used in the automotive, medical and industrial industries.

Our plan for the balance of 2016 is to concentrate our marketing efforts and limited financial resources on current projects that we believe can be brought to market in the shortest period of time. In July 2015 we announced the hiring of Mr. Paul Sexauer as a Vice President of Sales and Marketing with the intent of accelerating the introduction of our products into multiple markets. Since the hiring of Mr. Sexauer the Company has streamlined its efforts to work directly with customers, expand sales pipelines and finalize deals. We anticipate introducing additional products featuring our patented Bend Sensor^®technology into the market during 2016, including products in the medical, sport shoe, residential home care and industrial control industries.

We continue to develop new types of products for our Bend Sensor^®technologies and continue to receive small repeat production orders from existing customers. We have made improvements on our initial prototype for a Home Monitoring Presence Detection System using our Bend Sensor^®technologies and have received development and design orders from various industries. We have continued to work with market makers and Tier I automotive suppliers in the U.S and Europe on numerous other applications for our sensors and devises. Based upon our discussions within the automotive industry in the U.S. and Europe our unique sensor systems meet the requirements for manufacturers to have lighter weight, more fuel efficient cars. Our Bend Sensor^® is lighter in weight, has fewer moving parts than conventional sensing devices, is more versatile and, due to its unique design is more cost effective. Product and design changes in the automotive industry are slow, averaging two to three years before actually being incorporated into a commercially viable automotive platform. Because of our recent work with several Tier 1 suppliers, we have shown the Bend Sensor^® to be viable as the next generation of sensing devises to the industry. Due to the advanced technology of the Bend Sensor^® and its versatility of applications, we anticipate being a part of the changes taking place in the automotive, energy and technological industries.

In January 2016 the Company issued a press release detailing its accomplishments during 2015 and providing guidance relating to objectives and markets it has targeted for 2016. There has been increased activity in a number of these markets, which have resulted in additional press releases to keep the Company’s investors and the investor community at large updated.

In January 2016 the Company announced it has entered into a contract to co-develop a specialized Industrial Internet of Things (“IIOT”) application with a specialty equipment manufacturer in the energy industry. The customer designs, manufacturers and maintains “special use” equipment employed by hundreds of power companies to produce electricity and fulfill the real-time demands of the grid.

The Company made two additional announcements through press releases in February 2016. The first announced that it will partner with HTK Engineering, LLC, (“HTK”) on the go to market strategy development and sales execution of HTK’s anti-rollaway safety system. Rollaways occur weekly across a multitude of industries causing significant property damage and, in some cases personal injury and loss of life. The other release announced the progress rapidly being made on products in the toy industry and the rapidly growing wearables industries.

In March 2016 the Company issued an update on progress under the HTK project. A controls and distribution agreement has been entered into with New Eagle, who will serve as the primary supplier of controller systems (hardware and software) for the patented BrakeAlert system developed by HTK. The system features Flexpoint’s custom Bend Sensor^®.

The Company has issued additional press releases in April 2016. The first announced that full scale production for a number of different toy models will begin in June 2016. Annualized sensor order volumes are expected to be between 750,000 and 1,000,000 units in 2016, with significant annual increases thereafter.

The second release in April 2016 announced a conference call for investors held on April 19, 2016, during which the Company updated investors and the investor community on developments. During the call, the Company highlighted significant progress of Bend Sensor® driven technologies and projected revenue success in 2016. The Company noted that we were increasingly receiving orders from repeat and new customers from around the world and across industries. Flexpoint has completed or is on track to complete previously stated goals and the following contributors will allow the Company to achieve these previously stated cash flow and revenue goals:

Orders from a Fortune 100 global toy manufacturer with production products scheduled to hit consumer markets in late 2016.

An expanding number of wearables/gloves customers.

Rapid commercialization success of the recently patented HTK Safety Anti-Rollaway System with which Flexpoint has taken on a critical and expended sales and marketing leadership role.

A Tier 1 automotive manufacturer featuring the patented Flexpoint Horn Actuation system Haemoband, a European based medical device manufacturer which is expected to be successfully completing new product certification trials in mid/late 2016 and moving rapidly into mass production.

Also in April 2016, the Company announced a strategic partnership for the development of technology to allow computers to have any shape or form through flexible displays and other non-flat display technologies. It is anticipated that the actuation of these technologies may be enabled in large part through the integration of next generation materials, the Flexpoint Bend Sensor® technology and advanced power and electronics designs/techniques.

Our patented technology continues to gain recognition in various markets and industries as evidenced by the recent receipt of an initial production order from CPS Color Equipment S.p.A Italy and orders from a Fortune 100 automotive maker for our horn system. Although, so far the volumes for our applications and devises have been relatively small we continue to receive follow up orders for the universal sensor that we jointly developed last year. We expect to receive additional orders from other customers for this sensor as it becomes more recognizable in the market. Currently our customers for this type of sensor include companies in the following industries: automobiles, trucking, emergency vehicles, public transportation, military and other governmental entities. As anticipated, the Company is beginning to see the potential for more significant volumes and revenues from the sale of this sensing devise over the next year and beyond.

Finalizing additional long-term revenue generating production contracts with other customers remains our greatest challenge because our on-going business is dependent on the types of revenues and cash flows generated by such contracts. Cash flow and cash requirement risks are closely tied to, and are dependent upon, our ability to attract significant long-term production contracts. In the short term, we must continue to obtain funding to operate and expand our operations so that we can deliver our unique Bend Sensor^® and Bend Sensor^® related technologies and products to the market. Management believes that even though we have made positive strides forward with our business plan, it is likely that significant progress may not occur for the next three to six months, primarily due to

the time it takes for negotiating such contracts. Accordingly, we cannot guarantee that we will realize significant revenues or that we will become profitable over the next six to nine months.

LIQUIDITY AND CAPITAL RESOURCES

Our revenue is primarily from design, contract, testing and limited production services and is not to a level to support our operations. Management anticipates that we may not realize significant revenue within the next three to nine months.

Management believes that our current cash burn rate is approximately $60,000 per month and the proceeds from the convertible notes and our engineering and design fees will not totally fund our anticipated growth in operations. We will therefore need to raise additional financing. We believe that this additional financing will provide the needed capital to extend operations to the development and production of our growing product offerings and growing manufacturing opportunities. However, we may not be able to obtain financing, or the sources of financing, if any, may not continue to be available, and if available, they may be on terms unfavorable to us.

As we enter into production and development agreements, we must ensure that those agreements provide adequate funding for any pre-production research and manufacturing costs. As we are successful in establishing agreements with adequate initial funding, management believes that our operations for the long term will be funded by revenues, licensing fees and/or royalties related to these agreements. However, other than the recent development agreement with Bend Tech that we believe will provide future revenues, we have not formalized any additional agreements during the past year and there can be no assurance that the agreements we currently have will come to fruition in the near future or that a desired technological application can be brought to market on a commercially viable basis.

FINANCIAL OBLIGATIONS AND CONTINGENT LIABILITIES

Our principal commitments at March 31, 2016 consisted of our operating lease of $9,300 per month, and total liabilities of $1,028,162, which includes $382,380 of convertible notes payable, net of discounts of $616,077. Accrued liabilities at March 31, 2016, were $474,318 and were related to payroll, payroll tax liabilities, accrued professional expenses, accrued insurance expense, accrued interest expense on notes and accrued paid time off.

During the three months ending March 31, 2016, the Company has raised an additional $150,000 in operating capital through the issuance of short-term notes to a third party. The notes have an annual interest rate of 10% and a default rate of 15% annually. The notes, which total $958,457, are secured by the Company’s business equipment and have a conversion feature for restricted common shares at $0.05 and $0.06 per share with maturity dates of November 30 and December 31, 2016.

The Company has a major customer, Bend Tech, LLC, represents a significant portion of revenue, accounts receivable and notes receivable. During the three months ended March 31, 2016, the customer represented 28% of sales, represents 84% of accounts receivable and 100% of notes receivable at March 31, 2016. The Company has a strong relationship with this customer and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies. The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer.

OFF-BALANCE SHEET ARRANGEMENTS

Other than our current operating lease, we have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

CRITICAL ACCOUNTING ESTIMATES

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates of particular significance in our financial statements include goodwill and the annual tests for impairment of goodwill and long-lived assets and valuing stock option compensation.

The Company's goodwill represents the excess of its reorganization value over the fair value of the net assets upon emergence from bankruptcy. Goodwill is not amortized, therefore we test our goodwill for impairment annually or when a triggering event occur using a fair value approach. A fair value based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its nets assets. The test requires various judgments and estimates. During 2015 and for the three months ending March 31, 2016, the Company recorded no impairment charge to reduce the carrying value of the goodwill to its estimated fair value. As part of the impairment testing, the Company considered factors such as the global market volatility, variables in the economy, and the overall uncertainty in the markets which has resulted in a decline in the market price of the Company's stock price and market capitalization for a sustained period, as indicators for potential goodwill impairment. Based upon our analysis for the impairment test for the three months ended March 31, 2016 compared the carrying value of the Company's net assets to the estimated fair value of the overall Company, and the present values of projected net cash flows of the Company over the next three years, no impairment was recognized during the three months ended March 31, 2016.

We test long-lived assets for impairment annually or when a triggering event occurs. Impairment is indicated if undiscounted cash flows are less than the carrying value of the assets. The amount of impairment is measured using a discounted-cash-flows model considering future revenues, operating costs and risk-adjusted discount rate and other factors. The analysis compares the present value of projected net cash flows for the remaining current year and next two years against the carrying value of the long-lived assets. If the carrying values of the long lives assets exceed the present value of the discounted projected revenues an impairment expense would be recognized in the period and the carrying value of the assets would be adjusted accordingly. Under similar analysis no impairment charge was taken during the three month period ended March 31, 2016. Impairment tests will be conducted on a quarterly basis and, should they indicate a carrying value in excess of fair value, additional charges may be required.

Financial accounting standards require that recognition of the cost of employee services received in exchange for stock options and awards of equity instruments be based on the grant-date fair value of such options and awards and is recognized as an expense in operations over the period they vest. The fair value of the options we have granted is estimated at the date of grant using the Black-Scholes American option-pricing model. Option pricing models require the input of highly sensitive assumptions, including expected stock volatility. Also, our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimate. Management believes the best input assumptions available were used to value the options and that the resulting option values are reasonable. For the three month periods ended March 31, 2016 and 2015 we recognized $8,401 and $0, respectively, of stock-based compensation expense for our stock options and there is no additional unrecognized compensation cost related to employee stock options at the current time.

RESULTS OF OPERATIONS

The following discussions are based on the consolidated operations of Flexpoint Sensor Systems, Inc. and should be read in conjunction with our unaudited financial statements for the three months ended March 31, 2016 and 2015, included in Part I, Item 1, above, and the audited financial statements included in the Company’s annual report on Form 10-K for the years ended December 31, 2015 and 2014.

THREE MONTH PERIOD ENDED MARCH 31, 2016:


SUMMARY OF OPERATING RESULTS
	Three month period ended
	March 31, 2016	March 31, 2015
Design, contract and testing revenue	$ 35,165	$ 32,000
Total operating costs and expenses	282,564	256,539
Net other income (expense)	(221,976)	(254,148)
Net loss	(469,375)	(478,687)
Basic and diluted loss per common share	(0.01)	(0.01)

For the three months ending March 31, 2016 revenue was $35,165, a $3,165 increase when compared to the same period in 2015. The majority of the revenue for this period came from billable engineering services. The Company continues to concentrate its marketing resources on a limited number of customers that have the greatest potential to generate the most short-term revenue while still building relationships with our larger customers. Management

believes this approach has the highest potential to bring long-term commercially viable products to market and will provide sustainable cash flow to fund the Company's operations in the future. Currently, overall revenues are not sufficient to sustain our operations. Management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering. However, until a long-term production contract is in place there is no guarantee that our current customer base will order in sufficient volumes to sustain our operations. Therefore, management continues to work with larger companies and industries and is hopeful that in the near future we will sign a long-term licensing or manufacturing contract.

We received revenue from design contract, development engineering, limited production and repeat orders from our existing customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contract are met and then the sale is recognized as licensing royalty revenue over the remaining term of the contract. Revenue from the sale of a product is recorded at the time of shipment to the customer.

Of the $282,564 and $256,539 total operating costs and expense for the three months ending March 31, 2016 and 2015, respectively, $80,059 and $66,420 were for direct research and development cost, respectively. For the three months ended March 31, 2016, total operating expenses increased by $26,025 when compared to the same period in 2015, due primarily to the addition of another engineer to assist in product development.

Other expense for the three month period ended March 31, 2016 was $221,976, a $32,172 decrease compared to the same period in 2015. The decrease is attributable to the beneficial conversion charges on the convertible notes.

A net loss of $469,375 was realized for the three months ended March 31, 2016. A net loss of $478,687 was realized for the three month period ended March 31, 2015.

The chart below represents a summary of our condensed consolidated balance sheets at March 31, 2016 and December 31, 2015.


SUMMARY OF BALANCE SHEET INFORMATION

	March 31, 2016	December 31, 2015
Cash and cash equivalents	$ 32,779	$ 22,706
Total current assets	241,839	220,018
Total assets	5,300,857	5,302,777
Total liabilities	1,028,162	621,108
Deficit accumulated	(24,439,002)	(23,969,627)
Total stockholder’s equity	$ 4,272,695	$ 4,681,669

Cash and cash equivalents increased by $10,073 at March 31, 2016 compared to December 31, 2015. The increase in cash is due to the timing of payment of expenses, collection of accounts receivable and proceeds from borrowings. Our non-current assets decreased at March 31, 2016 due to the amortization of long-lived assets.

Total liabilities increased by $407,054 at March 31, 2016; the increase was primarily due to the funding of operations through the issuance of convertible notes payable, the accrued interest related to those notes, and accruals for investor relations and insurance expenses.

INFLATION

We do not expect the impact of inflation on our operations to be significant for the next twelve months.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

(a)

Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Our Chief Executive Officer and Principal Financial Officer evaluated whether information required to be disclosed is recorded, processed, summarized and reported within the specified periods, and is accumulated and communicated to management to allow for timely decisions regarding required disclosure of material information required to be included in our periodic Securities and Exchange Commission reports. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were effective for the three-month period ending March 31, 2016.

(b)

Changes in Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management reviewed our internal controls over financial reporting, and there have been no changes in our internal controls over financial reporting for the three month period ended March 31, 2016 that have materially affected, or are likely to affect, our internal controls over financial reporting.

PART II - OTHER INFORMATION

ITEM 1A. RISK FACTORS

We have a history of losses and may never become profitable.

We are unable to fund our day-to-day operations from revenues and the lack of revenues for continued growth may cause us to delay our business development. For the three months ending March 31, 2016, we had negative cash flows from operating activities of $138,012. We will require additional financing to fund our short-term cash needs and we may be required to rely on debt financing, loans from related parties, and private placements of our common stock for that additional funding. Such funding sources may not be available or the terms of such funding sources may not be acceptable to the company. If the Company is unable to find such funding it could have a material adverse effect on our ability to continue as a going concern.

We may not have adequate resources to successfully manage anticipated growth.

We may not be equipped to successfully manage any possible future periods of rapid growth or expansion, which could be expected to place a significant strain on our managerial, operating, financial and other resources. Our future performance will depend, in part, on our ability to manage growth effectively, which will require us to:

improve existing, and implement new, financial controls and systems, management information systems, operating, administrative, financial and accounting systems and controls,

maintain close coordination between engineering, programming, accounting, finance, marketing, sales and operations, and

attract and retain additional qualified technical and marketing personnel.

There is intense competition for management, technical and marketing personnel in our business. The loss of the services of any of our key employees or our failure to attract and retain additional key employees could have a material adverse effect on our ability to continue as a going concern.

We may not have adequate manufacturing capacity to meet anticipated manufacturing contracts.

We have completed installation of our first manufacturing line; however, our agreement with the Walker Group will allow us to delay installation and approval of a second production line. The second manufacturing line will be needed as a result of anticipated increased manufacturing demand and improved manufacturing efficiencies. We anticipate qualifying our manufacturing facility for ISO/TS-16949 certification as the Company successfully obtains

additional manufacturing contracts during the coming year. However, we cannot assure you that we will satisfy ISO/TS-16949 qualification or that the production lines will produce product in the volumes required or that the production lines will satisfy the requirements of our automotive customers.

Our success is dependent on our intellectual property rights which are difficult to protect.

Our future success depends on our ability to protect our intellectual property. We use a combination of patents and other intellectual property arrangements to protect our intellectual property. There can be no assurance that the protection provided by our patents will be broad enough to prevent competitors from introducing similar products or that our patents, if challenged, will be upheld by courts of any jurisdiction. Patent infringement litigation, either to enforce patents or defend ourselves from infringement suits, will be expensive and could divert our resources from other planned uses. Patent applications filed in foreign countries and patents in these countries are subject to laws and procedures that differ from those in the U.S. and may not be as favorable to us. We also attempt to protect our confidential information through the use of confidentiality agreements and by limiting access to our facilities. There can be no assurance that our program of patents, confidentiality agreements and restricted access to our facilities will be sufficient to protect our confidential information and intellectual properties from our competitors.

Research and development may result in problems which may become insurmountable to full implementation of production.

Customers request that we create prototypes and perform pre-production research and development. As a result, we are exposed to the risk that we may find problems in our designs that are insurmountable to fulfill production. In that event, we would be unable to recover the costs of the pre-production research and development. However, we are currently unaware of any insurmountable problems with ongoing research and development that may prevent further development of an application.

Because we are significantly smaller than the majority of our competitors, we may lack the financial resources needed to capture increased market share.

The market for sensor devices is extremely competitive, and we expect that competition will intensify in the future. There can be no assurance that we will be able to compete successfully against current or future competitors or that competitive pressures we face will not materially adversely affect our business, operating results or financial condition. Our primary competitors in the air bag market are International Electronics and Engineering, Siemens, Robert Bosch GmbH, Denso, Inc., Breed Technologies, TRW Automotive, Delphi Corporation, Autoliv Inc., Takata and Temic. We believe that none of our competitors have a product that is superior to our Bend Sensor^® technology at this time. However, many of our competitors and potential competitors have substantially greater financial, technical and marketing resources, larger customer bases, longer operating histories, greater name recognition and more established relationships than we do. These competitors may be able to undertake more extensive marketing campaigns, adopt more aggressive pricing policies and devote substantially more resources to developing new products and markets than we can.

Ongoing industry consolidation among worldwide automotive parts suppliers and financial difficulties of U.S. auto makers may limit the market potential for our products.

In the automotive parts industry, there is a trend of consolidation through business combinations and acquisitions of complementary technologies among worldwide suppliers as these suppliers seek to build stronger customer relationships with automobile manufacturers. Automobile manufacturers look to Tier 1 suppliers (major suppliers) to provide fully engineered systems and pre-assembled combinations of components rather than individual components. This trend of consolidation of suppliers may result in fewer Tier 1 suppliers and thus limit the marketing opportunities for our Bend Sensor^® technology

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company has not issued any securities since the year ended December 31, 2015.

ITEM 6. EXHIBITS

Part I Exhibits


No.	Description
31.1	Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32	Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley

Part II Exhibits


No.	Description
3.1	Certificate of Incorporation of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.1 for Form 10-QSB, filed August 4, 2006)
3.2	Bylaws of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.4 of Form 10-QSB, filed May 3, 2004)
10.1	Lease Agreement between Flexpoint Sensor and F.G.B.P., L.L.C., dated July 12, 2004 (Incorporated by reference to exhibit 10.2 of Form 10-QSB, filed November 15, 2004, as amended)
10.2	Addendum to Lease Agreement between Flexpoint Sensor and American Covers, Inc., dated March 29, 2012 (Incorporated by reference to exhibit 10.2 of Form 10-QSB, filed May 15, 2012)
10.3	Addendum to Lease Agreement between Flexpoint Sensor and Handstands, dated January 1, 2015. (Incorporated by reference to exhibit 10.3 of Form 10-K, filed April 14, 2016)
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, who is duly authorized.

FLEXPOINT SENSOR SYSTEMS, INC.

Date: May 16, 2016

/s/ Clark M. Mower

Clark M. Mower

President, Chief Executive Officer and Director,

Principal Financial Officer

EX-31 2 ex311.htm 302 CERTIFICATION OF CLARK M. MOWER, CEO Exhibit 31

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clark M. Mower certify that:

1. I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 16, 2016

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer

EX-31 3 ex312.htm 302 CERTIFICATION OF CLARK M. MOWER, CFO Converted by EDGARwiz

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clark M. Mower, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 16, 2016

/s/ Clark M. Mower

Clark M. Mower

Principal Financial Officer

EX-32 4 ex32.htm SECTION 1350 CERTIFICATION Exhibit 32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc. (the “Company”) for the period ending March 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Clark M. Mower, Chief Executive Officer and Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: May 16, 2016

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer

Principal Financial Officer

EX-101.INS 5 flxt-20160331.xml XBRL INSTANCE DOCUMENT 0000925660 2016-01-01 2016-03-31 0000925660 2016-05-16 0000925660 2016-03-31 0000925660 2015-12-31 0000925660 2015-01-01 2015-03-31 0000925660 2014-12-31 0000925660 2015-03-31 0000925660 us-gaap:MinimumMember 2016-01-01 2016-03-31 0000925660 us-gaap:MaximumMember 2016-01-01 2016-03-31 0000925660 us-gaap:SalesRevenueNetMember flxt:CustomerOneMember 2016-01-01 2016-03-31 0000925660 us-gaap:AccountsReceivableMember flxt:CustomerOneMember 2016-01-01 2016-03-31 0000925660 us-gaap:NotesReceivableMember flxt:CustomerOneMember 2016-01-01 2016-03-31 0000925660 flxt:NotesReceivableOneMember us-gaap:SettledLitigationMember flxt:ResearchAndDevelopmentProductsLLCMember 2013-04-08 2013-04-09 0000925660 flxt:NotesReceivableOneMember us-gaap:SettledLitigationMember flxt:ResearchAndDevelopmentProductsLLCMember 2013-04-09 0000925660 flxt:VariousConvertibleNotes2015Member 2015-12-31 0000925660 flxt:VariousConvertibleNotes2015Member us-gaap:MinimumMember 2015-12-31 0000925660 flxt:VariousConvertibleNotes2015Member us-gaap:MaximumMember 2015-12-31 0000925660 flxt:NotesPayableThirdPartiesMember 2015-12-31 0000925660 flxt:NewConvertibleNotesPayableOneMember 2015-12-31 0000925660 flxt:NewConvertibleNotesPayableTwoMember 2015-12-31 0000925660 2015-01-01 2015-12-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember 2016-01-01 2016-03-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember 2016-03-31 0000925660 2006-01-01 2015-12-31 0000925660 us-gaap:RestrictedStockMember 2015-10-01 2015-10-31 0000925660 us-gaap:RestrictedStockMember 2015-11-01 2015-12-31 0000925660 flxt:The2014CapitalCommunicationNotesWithAdditional2015FinancingMember flxt:DebtConversionJanuary2015TransactionOneMember 2016-01-01 2016-03-31 0000925660 flxt:The2014CapitalCommunicationNotesWithAdditional2015FinancingMember flxt:DebtConversionJanuary2015TransactionTwoMember 2016-01-01 2016-03-31 0000925660 flxt:RandDProductsLlcMember 2016-03-31 0000925660 us-gaap:ChiefExecutiveOfficerMember 2016-03-31 0000925660 us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000925660 flxt:NewConvertibleNotesPayableTwoMember 2015-01-01 2015-12-31 0000925660 flxt:NewConvertibleNotesPayableOneMember 2015-01-01 2015-12-31 0000925660 flxt:NotesPayableThirdPartiesMember 2015-01-01 2015-12-31 0000925660 flxt:The2016CapitalCommunicationNotesMember 2016-01-20 0000925660 flxt:The2016CapitalCommunicationNotesMember flxt:DebtIssuanceTrancheOneMember 2016-01-20 0000925660 flxt:The2016CapitalCommunicationNotesMember 2016-01-01 2016-03-31 0000925660 us-gaap:SubsequentEventMember flxt:ConvertiblePromissoryNoteMember 2016-04-28 2016-04-29 0000925660 us-gaap:SubsequentEventMember flxt:ConvertiblePromissoryNoteMember 2016-04-29 0000925660 flxt:The2016CapitalCommunicationNotesMember 2016-01-19 2016-01-20 0000925660 flxt:StockIncentivePlan2005Member 2016-01-01 2016-03-31 0000925660 flxt:StockIncentivePlan2005Member 2016-03-31 0000925660 us-gaap:EmployeeStockOptionMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember us-gaap:DirectorMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember flxt:EmployeeMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeOneMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeTwoMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeThreeMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeFourMember flxt:StockIncentivePlan2005Member 2015-08-23 2015-08-24 0000925660 us-gaap:EmployeeStockOptionMember flxt:StockIncentivePlan2005Member 2005-08-25 2015-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember 2015-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2015-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember 2005-08-25 2015-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2005-08-25 2015-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 71627114 0000925660 2016-03-31 --12-31 Smaller Reporting Company 2016 Q1

32779

22706

7140

111027

98557

88721

86806

9312

11949

241839

6550

586394

816844

155551

179292

4896917

5302777

168429

160437

322

474318

375244

616077

342380

40000

1028162

621108

0.001

100000000

71627114

71627

9958

28629112

-23969627

4681669

5300857

5302777

71627114

100000000

1000000

32000

23741

25585

1344

2827

80059

282564

256539

223891

1915

-55661

-168286

-469375

-478687

-0.01

71627114

57864114

1000

8401

198275

110872

12470

-21120

7992

-5876

2713

1561

99074

83409

-138012

-129406

-1915

120000

150000

120000

10073

-9406

18307

8901

305073

1079453

9958 51000 1009048

0.84

1.00

0.15

51157

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   <div> Condensed Consolidated Interim Financial Statements The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the Company). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2015 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 14, 2016. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2016. </div>   <div> Nature of Operations The Company is located near Salt Lake City, in Draper, Utah and is a company engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company suffered losses of $469,375 and $478,687 and used cash in operating activities of $138,012 and $129,406 during the three months ended March 31, 2016 and 2015, respectively. Through March 31, 2016, the Company had an accumulated deficit of $24,439,002. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. </div>   <div> Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $32,779 at March 31, 2016 and $22,706 at December 31, 2015 represent cash on deposit in various bank accounts with a financial institution. </div>    <div> Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates that approximate current market rates. </div>   <div> Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees, and are shown net of the allowance for bad debts. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured. While the Company has historically experienced very minimal bad debts it felt it prudent to create an allowance for doubtful accounts to provide for any risk associated with bad debts on current receivables.   Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such a contract additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. </div>   <div> Inventories Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.  Inventories consist of raw materials. </div>   <div> Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. </div>   <div> Valuation of Long-lived Assets The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of March 31, 2016. </div>   <div> Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of March 31, 2016. </div> <div> Research and Development Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. </div>   <div> Goodwill Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in ASC 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events; such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods. </div>   <div> Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. </div>   <div> Stock-Based Compensation Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. </div>   <div> Basic and Diluted Earnings (loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period.  Diluted earnings per share is computed by dividing net earnings (loss) by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 21,720,103 shares of common stock.  These common stock equivalents were not included in the computation of diluted loss as their effect would be anti-dilutive.  Other convertible notes and options- related exercise prices were less than the average market price of the common stock. </div>   <div> Concentrations and Credit Risk - The Company has a major customer who represents a significant portion of revenue, accounts receivable and notes receivable.  During the three months ended March 31, 2016, the customer represented 28% of sales and represents 84% of accounts receivable and 100% of notes receivable at March 31, 2016. The Company has a strong relationship with this customer and does not believe this concentration poses a significant risk, as their products are based entirely on the Company's technologies.  The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer. </div> <div> Recent Accounting Pronouncements - In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update ("ASU") 2016-02, Leases.  This ASU requires lessees to put most leases on their balance sheets but recognize expenses in the income statement in a manner similar to current accounting treatment.  This ASU changes the guidance on sale-leaseback transactions, initial direct costs and lease execution costs, and, for lessors, modifies the classification criteria and the accounting for sales-type and direct financing leases.  For public business entities, this ASU is effective for annual periods beginning after December 15, 2018, and interim periods therein.  Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements.  The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.   In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows.  The guidance is effective for fiscal years beginning after December 15, 2016, although early adoption is permitted.  The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.   The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </div> </div>

0.001

35165

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Nature of Operations The Company is located near Salt Lake City, in Draper, Utah and is a company engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company suffered losses of $469,375 and $478,687 and used cash in operating activities of $138,012 and $129,406 during the three months ended March 31, 2016 and 2015, respectively. Through March 31, 2016, the Company had an accumulated deficit of $24,439,002. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $32,779 at March 31, 2016 and $22,706 at December 31, 2015 represent cash on deposit in various bank accounts with a financial institution. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates that approximate current market rates. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of March 31, 2016. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Goodwill Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in ASC 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events; such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Stock-Based Compensation Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Recent Accounting Pronouncements - In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update ("ASU") 2016-02, Leases.  This ASU requires lessees to put most leases on their balance sheets but recognize expenses in the income statement in a manner similar to current accounting treatment.  This ASU changes the guidance on sale-leaseback transactions, initial direct costs and lease execution costs, and, for lessors, modifies the classification criteria and the accounting for sales-type and direct financing leases.  For public business entities, this ASU is effective for annual periods beginning after December 15, 2018, and interim periods therein.  Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements.  The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.   In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows.  The guidance is effective for fiscal years beginning after December 15, 2016, although early adoption is permitted.  The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.   The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </div>

P5Y

P15Y

21720103

0.28

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> NOTE 2 NOTES RECEIVABLE   On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the managing member of R&D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&D Products and Mr. deGreef, specifically patented applications using Bend Sensor® technology that were filed jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor® applications for R&D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&D belong to Flexpoint and therefore is sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&D Products.    On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $25,000 to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of 10% to be paid no later than December 31, 2015.  The Company is currently evaluating actions it should take relative to this note receivable which is in default.    On April 1, 2015, the Company paid $51,157 for the assumption and assignment of a convertible promissory note receivable issued by Bend Tech, LLC (Bend Tech; one of the Company's customers see also Note 1, Concentrations and Credit Risk) and held by a third-party Bend Tech investor (the Investor).  The note bears   interest at the rate of 10% per annum and had a maturity date of April 1, 2015.  The agreement allows the holder, at its option, to convert the note to a 5% ownership of Bend Tech.  The Company elected to take assignment of those conversion rights, reaching an agreement with the Investor to pay the principal and interest to the Investor at the due date.  Bend Tech is expected to become a more significant customer of the Company as it begins its product introductions, and the Company elected to pay off the note and put itself in position to either receive the payment plus interest or   convert the note into ownership of Bend Tech rather than have an outside investor make such conversion.  As of the date of this report, the note is in default and the Company has not exercised its conversion option. </div>

25000

0.10 2015-04-01

0.1

0.15

0.07

51000

0.1

684660

123797

0.1

0.15

300000

50000

0.1

0.06

998457

49217

198275

40000

0.1

0.15 23760

2650000

0.06

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">NOTE 3 CONVERTIBLE NOTES PAYABLE Convertible Notes PayableDuring 2015, the Company secured additional financing to cover its ongoing operations in the amount of $590,000 by issuing various convertible notes bearing 10% annual interest (15% default interest), secured by business assets and carrying exercise prices ranging between $0.025 and $0.07 per share. Additionally during 2015, the Company issued $51,000 for a non-convertible note payable bearing 10% annual interest (15% default interest) and secured by the $51,157 note receivable held by the Company (see Note 2). During 2015, all of these notes (both convertible and non-convertible issued in 2014 and 2015) and accrued interest were either converted into common stock or extinguished and consolidated into two remaining convertible notes payable to two investors in principal amounts of $684,660 and $123,797 (with respective maturity dates of December 31, 2016 and November 30, 2016). Both notes are convertible at $0.05 per share, bear 10% annual interest rates (15% default interest) and are secured by business assets.  On January 20, 2016, the Company entered into a promissory convertible note with Capital Communications LLC for up to $300,000 which is expected to be funded in tranches of $50,000 for each of the six months thereafter.  Accordingly, on January 26, 2016, February 26, 2016 and March 31, 2016, the Company received proceeds for an aggregate total of $150,000 from Capital Communications LLC. The note has an annual interest rate of 10% and is secured by the Company's business equipment. The principal amount of the note, and all accrued interest is due and payable on or before December 31, 2016 and each note has a conversion feature for restricted common shares at $0.06 per share. At March 31, 2016, the Convertible Notes Payable principal is $998,457, the unamortized discount is $616,077 and interest accrued and unpaid is $49,217.  The Company recorded interest expense of $198,275 during the three months ended March 31, 2016 as it amortized the discount charges generated by the issuance of convertible notes payable. Convertible Note Payable Related Party On August 8, 2011, the Company entered into a convertible note payable with a Company Director for $40,000. This note is due on December 31, 2015, bears an annual interest rate of 10% annual interest (15% default interest) and is secured by business equipment.</div>

2015-04-01

2016-11-30

2016-12-31

0.15

0.05

2015-12-31

2011-08-08

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> NOTE 5 CAPITAL STOCK   Preferred Stock There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized.  At March 31, 2016 and December 31, 2015, there were no shares of preferred stock issued or outstanding.   Common Stock There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized.  No shares of stock were issued during the three months ended March 31, 2016.    On January 12, 2015, the Board of Directors approved the conversion of $165,000 in convertible notes held by Capital Communications LLC, plus $33,023 in interest accrued and unpaid, to 2,800,000 shares of restricted common stock at an average conversion price of $0.07 per share   On January 20, 2015, the Board of Directors approved the conversion of $135,000 in convertible notes held by Empire Fund Managers, plus $23,760 in interest accrued and unpaid, to 2,650,000 shares of restricted common stock at an average conversion price of $0.06 per share.   In October 2015, the Board of Directors approved the issuance of 3,400,000 shares of restricted common stock to extinguish $330,000 in accrued liabilities arising from investor relations services, at an average price of $0.084 per share.   In November and December 2015, the Board of Directors approved the conversion of $470,000 in convertible notes to 9,400,000 shares of restricted common stock.   </div>

1000000

0.001

165000

33023

2800000

0.07

135000

3400000

330000 0.084

470000

9400000

2015-01-12

2017-12-31

8950 9600

0.06

2016-12-31

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">NOTE 6 - COMMITMENTS AND CONTINGENCIES The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017.  Either party may terminate the lease upon 90 day written notice.  Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), and will pay $9,300 per month in 2016 and $9,600 per month in 2017.  In September 2005 the Company entered into a manufacturing agreement with R&D Products, LLC, a Utah limited liability company, doing business in Midvale, Utah.  For the purpose of this contract, management considers R&D Products to be a related party because a controlling member of R&D Products, LLC is also a non-controlling shareholder of Flexpoint Sensor Systems, Inc.  R&D Products has developed a mattress with multiple air chambers that uses the Company's Bend Sensors® and the Company has entered into an agreement to manufacture the Bend Sensors® for R&D's specific mattress use.  The initial order is for 30,000 Bend Sensors® to be used to begin manufacture of 1,000 mattresses.  During 2007 and 2008 R&D Products deposited with Flexpoint the sum of $100,000 to begin work on the initial production order of 20 commercial beds.  Additional revenue from this contract is dependent upon R&D Products selling either their bed technology directly or licensing their technology to a third party.  On September 11, 2008 R&D Products, LLC entered into a long-term Licensing Agreement for their bed technology with a major medical solutions provider (Licensee). The Agreement provides the Licensee the exclusive worldwide rights to R&D's patented medical bed technology. On that same day the Company, R&D Products and the Licensee entered into a long-term joint manufacturing agreement for R&D's medical bed technology and related products. The manufacturing agreement allows for the Company to manufacture sensors for the bed technology and related medical products through 2018 with an option to renew each year thereafter. Production schedules with specific quantities and deadlines are still being outlined. (See Note 2). At this time management is unsure the effect their litigation with R&D will have on this agreement with R&D or its Licensee.   The Company is currently evaluating actions it should take relative to the notes receivable referenced in Note 2, which are in default. </div>

100000

3035

2016-04-29

50000

300000

0.1

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees, and are shown net of the allowance for bad debts. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured. While the Company has historically experienced very minimal bad debts it felt it prudent to create an allowance for doubtful accounts to provide for any risk associated with bad debts on current receivables.   Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such a contract additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="display: block;"> NOTE 4 STOCK OPTION PLANS   On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company's trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares. The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.   On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company's common stock.  Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees.  Of the options issued, 640,000 have an option price of $0.14 per share, 900,000 have an option price of $0.15 per share, 595,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share.  Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively.  We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.   Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.  Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share.  The options vest over three years and expire 10 years from the date of grant.  The Company used the following assumptions in estimating the fair value of the options granted:   <ul style="margin: 0pt; padding-left: 0pt;" type="disc"> <li style="font-family: symbol; font-size: 10pt; line-height: 10.65pt; margin: 0pt 0pt 0pt 66pt; padding-left: 8.4pt; text-indent: 0pt; list-style-position: outside;">Market value at the time of issuance Range of $0.14 to 2.07</li> <li style="font-family: symbol; font-size: 10pt; line-height: 10.65pt; margin: 0pt 0pt 0pt 66pt; padding-left: 8.4pt; text-indent: 0pt; list-style-position: outside;">Expected term Range of 3.7 years to 10.0 years</li> <li style="font-family: symbol; font-size: 10pt; line-height: 10.65pt; margin: 0pt 0pt 0pt 66pt; padding-left: 8.4pt; text-indent: 0pt; list-style-position: outside;">Risk-free interest rate Range of 1.60% to 4.93%</li> <li style="font-family: symbol; font-size: 10pt; line-height: 10.65pt; margin: 0pt 0pt 0pt 66pt; padding-left: 8.4pt; text-indent: 0pt; list-style-position: outside;">Dividend yield 0%</li> <li style="font-family: symbol; font-size: 10pt; line-height: 10.65pt; margin: 0pt 0pt 0pt 66pt; padding-left: 8.4pt; text-indent: 0pt; list-style-position: outside;">Expected volatility 200% to 424%</li> <li style="font-family: symbol; font-size: 10pt; line-height: 10.65pt; margin: 0pt 0pt 0pt 66pt; padding-left: 8.4pt; text-indent: 0pt; list-style-position: outside;">Weighted-average fair value - $0.16 to $2.07</li> </ul>   As of the three months ended March 31, 2016 and the years ended December 31, 2005 through 2015, the Company recognized a total of $2,398,185 of stock-based compensation expense, leaving $37,698 in unrecognized expense as of March 31, 2016. There were 2,185,000 and 2,185,000 employee stock options outstanding at March 31, 2016 and December 31, 2015, respectively.     A summary of all employee options outstanding and exercisable under the plan as of March 31, 2016, and changes during the three months then ended is set forth below:   <div> <table style="border-collapse: collapse;" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';"> Options </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" align="center"> Shares </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="2" align="center"> Weighted Average Exercise Price </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="2" align="center"> Weighted Average Remaining Contractual  Life (Years) </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="3" align="center"> Aggregate Intrinsic Value </td> </tr> <tr> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px; text-align: left;"></td> <td style="vertical-align: top; font-family: 'times new roman'; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" align="center"></td> <td style="vertical-align: top; font-family: 'times new roman'; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" colspan="2" align="center"></td> <td style="vertical-align: top; text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" colspan="2" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" colspan="3" align="center"> </td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; width: 53%;"> Outstanding at the beginning of period </td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 1%;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 10%;" align="right">2,185,000</td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 2%;"> </td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 9%;" align="right">0.16</td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 2%;"> </td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 9%;" align="right">9.66</td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 2%;"> </td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 8%;" align="right">--</td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';">    Granted </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';">    Expired </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; font-weight: bold; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; font-weight: bold; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; font-weight: bold; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';">    Forfeited </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';"> Outstanding at the end of Period </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">2,185,000</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">0.16</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">9.41</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';"> Exercisable at the end of Period </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">1,755,000</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">0.15</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">9.41</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> </table> </div> </div> </div>

P10Y

2500000

225000

640000

0.14

595000

50000

0.25

3096000

0.14

2.07

P3Y

2.07

P3Y8M12D

P10Y

0.0493

0.00

2.00

2185000

0.16

P9Y7M28D

2185000

1755000

P9Y4M28D

2398185

150000

2016-12-31

2016-01-20

false FLEXPOINT SENSOR SYSTEMS INC

6550

3035

45105

71627

28569711

7140

0.001

-221976

-2637

1915

150000

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Inventories Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.  Inventories consist of raw materials. </div>

51157

0.10 0.05

590000

0.025

0.05

9300

322

2185000

900000

0.20

0.0160

4.24

0.16

2.07

P9Y4M28D

37698

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="border-collapse: collapse;" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';"> Options </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" align="center"> Shares </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="2" align="center"> Weighted Average Exercise Price </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="2" align="center"> Weighted Average Remaining Contractual  Life (Years) </td> <td style="vertical-align: bottom; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" align="center"> </td> <td style="vertical-align: bottom; border-bottom: #000000 1pt solid !important; padding: 0px; font-family: 'Times New Roman';" colspan="3" align="center"> Aggregate Intrinsic Value </td> </tr> <tr> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px; text-align: left;"></td> <td style="vertical-align: top; font-family: 'times new roman'; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" align="center"></td> <td style="vertical-align: top; font-family: 'times new roman'; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" colspan="2" align="center"></td> <td style="vertical-align: top; text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" colspan="2" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; padding: 0px; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"> </td> <td style="vertical-align: top; font-family: 'times new roman'; border-top: #000000 1pt solid !important; padding: 0px;" colspan="3" align="center"> </td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman'; width: 53%;"> Outstanding at the beginning of period </td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 1%;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 10%;" align="right">2,185,000</td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 2%;"> </td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 9%;" align="right">0.16</td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 2%;"> </td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 9%;" align="right">9.66</td> <td style="vertical-align: bottom; padding: 0px 5px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; width: 2%;"> </td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 8%;" align="right">--</td> <td style="padding: 0px 5px 0px 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; width: 1%;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';">    Granted </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';">    Expired </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; font-weight: bold; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; font-weight: bold; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; font-weight: bold; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';">    Forfeited </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';"> Outstanding at the end of Period </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">2,185,000</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">0.16</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">9.41</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> <tr> <td style="vertical-align: bottom; padding: 0px; font-family: 'Times New Roman';"> Exercisable at the end of Period </td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">1,755,000</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">0.15</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">9.41</td> <td style="vertical-align: bottom; padding: 0px; text-align: right; font-family: 'Times New Roman'; font-size: 9pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"> </td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap;" align="right">--</td> <td style="padding: 0px; font-family: 'Times New Roman'; font-size: 9pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> </tr> </table> </div>

10-Q

5300857

220018

10958

-24439002

4272695

793103

763352

177420

161707

66420

141538

-254148

-0.01

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Research and Development Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. </div>

<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> Concentrations and Credit Risk - The Company has a major customer who represents a significant portion of revenue, accounts receivable and notes receivable.  During the three months ended March 31, 2016, the customer represented 28% of sales and represents 84% of accounts receivable and 100% of notes receivable at March 31, 2016. The Company has a strong relationship with this customer and does not believe this concentration poses a significant risk, as their products are based entirely on the Company's technologies.  The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer. </div>

0.1

2015-01-20

1960000

0.15

P10Y

0.14

0.16

0.15

EX-101.SCH 6 flxt-20160331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NOTES RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 8003 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 8004 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - STOCK OPTION PLANS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) link:presentationLink link:calculationLink link:definitionLink 8005 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 8006 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 8007 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCK OPTION PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - NOTES RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 8011 - Disclosure - INCOME TAXES (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 8013 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 8014 - Disclosure - INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - CAPITAL STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 flxt-20160331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 flxt-20160331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 flxt-20160331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Gain (loss) on stock debt exchange. Gain on conversion of notes The term of the stock incentive plan unless otherwise terminated. Effective term The amount of related party debt discount (net of debt premium) that was originally recognized at the issuance of the instrument that has yet to be amortized. Convertible notes payable to related party, discount Loss on conversion of notes payable to common stock. (Gain)/loss on conversion of notes payable to common stock Gain on conversion of notes The (gain) loss on forgiveness of debt. Gain (Loss) Debt Forgiveness Recognition of discounts on convertible notes payable. Recognition of discounts on convertible notes payable Amount of required minimum monthly rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Lease, monthly payment in 2016 Amount of required minimum monthly rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Lease, monthly payment in 2017 Amendment Flag Stock subscription for compensation. Stock subscription for compensation Note receivable interest income. NoteReceivableInterestIncome Note receivable interest income Common shares issued in conversion of debt. Common stock issued for debt conversion The agreement allows the holder, at its option, to convert the note to a ownership percentage of Bend Tech, LLC. Conversion right, ownership percentage Interest rate on notes receivable. Interest rate Maturity date of notes receivable. Maturity date Accrued liabilities extinguished from issuance of restricted common stock. Accrued liabilities extinguished from issuance of restricted common stock Lease, monthly payment in 2015. Lease, monthly payment in 2015 This item represents the default rate of debt instrument. Debt instrument, default rate The value of the accrued interest of the original debt that is being converted into in a noncash (or part noncash) transaction. Conversion of convertible notes, interest accrued and unpaid, amount The average conversion price for converted debt instruments. Average conversion price for converted debt instruments Options granted, weighted average remaining contractual term. Granted Aggregate intrinsic value of options granted during the period. ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue Granted Aggregate intrinsic value of options that expired during the period. ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredIntrinsicValue Expired Aggregate intrinsic value of options forfeited during the period. ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue Forfeited Current Fiscal Year End Date Stock subscriptions payable. Stock subscription payable Stock subscription payable Common shares issued in settlement of accrued liabilities. Common shares issued in settlement of accrued liabilities Convertible notes payable, principal amount outstanding. Convertible notes payable, principal amount outstanding Total common shares issued during period. Total common shares issued during period Loss (gain) on forgiveness of debt. LossGainOnForgivenessOfDebt Loss (Gain) on forgiveness of debt The accounting policy relating to the financial condition of the company. Business Condition Represents R&D Products, LLC. Rand DProducts Llc [Member] Document Period End Date Customer One [Member] Customer One [Member] R&D Products, LLC [Member] R&D Products, LLC [Member] Information on the note receivable, an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s). Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Notes Receivable One [Member] The 2014 Capital Communication Notes [Member] The 2014 Capital Communication Notes [Member] Award Type [Axis] Various Convertible Notes [Member] 2015 Various Convertible Notes [Member] The 2014 Capital Communication Notes With Additional 2015 Financing [Member] The $1,125,000 [Member] Debt Conversion January 2015 Transaction One [Member] Debt Conversion, January 12, 2015 [Member] Debt Conversion January 2015 Transaction Two [Member] Debt Conversion, January 20, 2015 [Member] Notes Payable Third Parties [Member] Notes Payable Third Parties [Member] Customer Two [Member] Customer Two [Member] Employee [Member] Employee [Member] Exercise price range one [Member] Exercise Price Range One [Member] Exercise price range two [Member] Exercise Price Range Two [Member] Exercise price range three [Member] Exercise Price Range Three [Member] Exercise price range four [Member] Exercise Price Range Four [Member] 2016 Capital Communication Notes [Member] The 2016 Capital Communication Notes [Member] Debt Issuance Tranche One [Member] Debt Issuance, Each of Six Months After Issuance [Member] New Convertible Notes Payable One [Member] New Convertible Notes Payable One [Member] New Convertible Notes Payable Two [Member] New Convertible Notes Payable Two [Member] Convertible Notes Payable Related Party [Member] Convertible Notes Payable to Related Party [Member] Document And Entity Information [Abstract]. Document and Entity Information [Abstract] Information contained within the Nature of Business disclosure. Nature Of Business [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Nature Of Business [Line Items] Legal Proceedings [Table] Legal Proceedings [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Legal Proceedings [Line Items] Loss on conversion of notes payable to common stock. Gain on stock debt exchange Represents the rate at which option awards are expected to be forfeited. Option forfeiture rate Weighted average remaining contractual life of options that expired during the period. SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpiredWeightedAverageRemainingContractualTerm1 Expired Weighted average remaining contractual life of options forfeited during the period. SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm1 Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value Debt Issuance [Axis] Debt Issuance [Axis] DebtIssuanceAxis [Axis] Debt Issuance [Domain] Disclosure of accounting policy for nature of operations. Nature Of Operations [Policy Text Block] Nature of Operations Represents information pertaining to convertible promissory note. Convertible Promissory Note [Member] Dollar amount of subscriptions to be paid during the period to investors who have been allocated common stock. Subscription Payable to Employee Subscription payable to employee Represents information pertaining to 2005 Stock Incentive Plan (the Plan). Stock Incentive Plan 2005 [Member] 2005 Stock Incentive Plan [Member] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Receivable Type [Axis] Accounts Receivable [Member] Accounts payable Accounts receivable, net of allowance for bad debts of $7,140 and $7,140 Accounts payable - related party Accrued liabilities Property and Equipment, accumulated depreciation Less: Accumulated depreciation Additional paid-in capital Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense. Accounts receivable, allowance for bad debts Amortization of discount on note payable Amortization expense Amortization of patents and proprietary technology Amortization expense Anti-dilutive securities excluded from computation of earnings per share amount ASSETS. Assets Total Assets Assets, Current Total Current Assets Current Assets Cash and Cash Equivalents. Cash and cash equivalents Cash and Cash Equivalents at End of Period Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents, Period Increase (Decrease) Net Change in Cash and Cash Equivalents Chief Executive Officer [Member] Commitments and contingencies. COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES [Abstract] Common stock - $0.001 par value; 100,000,000 shares authorized; 71,627,114 shares and 71,627,114 shares issued and outstanding Common stock, shares issued Common stock, shares authorized Common stock, par value per share Common stock, shares outstanding Balance, shares Balance, shares Concentration Risk Benchmark [Domain] Concentrations and Credit Risk Risk percentage Concentration Risk Benchmark [Axis] Condensed Consolidated Interim Financial Statements Convertible notes payable, balance Convertible notes payable, net of discount of $616,077 and $763,352 Cost of revenue Debt Conversion [Table] Debt Instrument [Line Items] Conversion of convertible notes, amount Shares issued from conversion of convertible debt Conversion of convertible notes, shares issued Beneficial conversion feature Debt instrument, maturity date range end CONVERTIBLE NOTES PAYABLE [Abstract] Debt conversion, date Debt Conversion [Line Items] Schedule of Long-term Debt Instruments [Table] Convertible debt, amount converted Debt instrument, issuance date Debt Conversion, Name [Domain] Debt Instrument [Axis] CONVERTIBLE NOTES PAYABLE Debt instrument, collateral amount Debt Conversion Description [Axis] Conversion of note payable, conversion price per share Debt instrument, conversion price Debt instrument, maturity date Debt Instrument, Name [Domain] Debt instrument, face amount Debt instrument, interest rate Convertible notes payable, discount Discount balance Deferred Tax Assets, Property, Plant and Equipment Patents and proprietary technology Deferred Tax Assets, Net of Valuation Allowance Net Deferred Tax Asset Operating loss carry forwards Deferred Tax Assets, Gross Total Deferred Tax Assets EX-101.PRE 10 flxt-20160331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2016	May. 16, 2016
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Entity Registrant Name	FLEXPOINT SENSOR SYSTEMS INC
Entity Central Index Key	0000925660
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		71,627,114

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 32,779	$ 22,706
Accounts receivable, net of allowance for bad debts of $7,140 and $7,140	111,027	98,557
Notes receivable	88,721	86,806
Deposits and prepaid expenses	9,312	11,949
Total Current Assets	241,839	220,018
Long-Term Deposits	$ 6,550	$ 6,550
Property and Equipment, net of accumulated depreciation of $586,394 and $586,394
Patents and Proprietary Technology, net of accumulated amortization of $816,844 and $793,103	$ 155,551	$ 179,292
Goodwill	4,896,917	4,896,917
Total Assets	5,300,857	5,302,777
Current Liabilities
Accounts payable	168,429	160,437
Accounts payable - related party	3,035	322
Accrued liabilities	474,318	375,244
Convertible notes payable, net of discount of $616,077 and $763,352	342,380	45,105
Convertible notes payable - related party	40,000	40,000
Total Liabilities	$ 1,028,162	$ 621,108
Stockholders' Equity
Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding
Common stock - $0.001 par value; 100,000,000 shares authorized; 71,627,114 shares and 71,627,114 shares issued and outstanding	$ 71,627	$ 71,627
Stock subscription payable	10,958	9,958
Additional paid-in capital	28,629,112	28,569,711
Accumulated deficit	(24,439,002)	(23,969,627)
Total Stockholders' Equity	4,272,695	4,681,669
Total Liabilities and Stockholders' Equity	$ 5,300,857	$ 5,302,777

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]
Accounts receivable, allowance for bad debts	$ 7,140	$ 7,140
Property and Equipment, accumulated depreciation	586,394	586,394
Patents and Proprietary Technology, accumulated amortization	816,844	793,103
Convertible notes payable, discount	$ 616,077	$ 763,352
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	71,627,114	71,627,114
Common stock, shares outstanding	71,627,114	71,627,114

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Design, Contract and Testing Revenue	$ 35,165	$ 32,000
Operating Costs and Expenses
Amortization of patents and proprietary technology	23,741	25,585
Cost of revenue	1,344	2,827
Administrative and marketing expense	177,420	161,707
Research and development expense	80,059	66,420
Total Operating Costs and Expenses	282,564	256,539
Other Income and Expenses
Interest expense	(223,891)	(141,538)
Interest income	$ 1,915	15
Gain on conversion of notes		55,661
Loss on extinguishment of debt		(168,286)
Net Other Income (Expense)	$ (221,976)	(254,148)
Net Loss	$ (469,375)	$ (478,687)
Basic and Diluted Loss per Common Share	$ (0.01)	$ (0.01)
Basic and Diluted Weighted Average Common Shares Outstanding	71,627,114	57,864,114

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows from Operating Activities:
Net loss	$ (469,375)	$ (478,687)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock subscription for compensation	1,000
Stock-based compensation expense	8,401
Amortization of patents and proprietary technology	23,741	$ 25,585
Amortization of discount on note payable	$ 198,275	110,872
Loss on extinguishment of debt		168,286
(Gain)/loss on conversion of notes payable to common stock		(55,661)
Changes in operating assets and liabilities:
Accounts receivable	$ (12,470)	21,120
Deposits and prepaid expenses	2,637	(15)
Accounts payable	7,992	(5,876)
Accounts payable - related parties	2,713	1,561
Accrued liabilities	99,074	83,409
Net Cash Used in Operating Activities	(138,012)	$ (129,406)
Cash Flows from Investing Activities:
Note receivable interest income	(1,915)
Net Cash Used in Investing Activities	(1,915)
Cash Flows from Financing Activities:
Proceeds from borrowings under convertible note payable	150,000	$ 120,000
Net Cash Provided by Financing Activities	150,000	120,000
Net Change in Cash and Cash Equivalents	10,073	(9,406)
Cash and Cash Equivalents at Beginning of Period	22,706	18,307
Cash and Cash Equivalents at End of Period	$ 32,779	$ 8,901
Supplemental Cash Flow Information:
Cash paid for income taxes
Cash paid for interest
Supplemental Disclosure on Noncash Investing and Financing Activities
Common stock issued for debt conversion		$ 305,073
Convertible notes issued and debt discount relieved in debt extinguishment		1,079,453
Subscription payable to employee		9,958
Recognition of discounts on convertible notes payable	$ 51,000	$ 1,009,048

XML 16 R6.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Mar. 31, 2016
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1– SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2015 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 14, 2016. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2016. Nature of Operations – The Company is located near Salt Lake City, in Draper, Utah and is a company engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company suffered losses of $469,375 and $478,687 and used cash in operating activities of $138,012 and $129,406 during the three months ended March 31, 2016 and 2015, respectively. Through March 31, 2016, the Company had an accumulated deficit of $24,439,002. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $32,779 at March 31, 2016 and $22,706 at December 31, 2015 represent cash on deposit in various bank accounts with a financial institution. Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates that approximate current market rates. Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees, and are shown net of the allowance for bad debts. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured. While the Company has historically experienced very minimal bad debts it felt it prudent to create an allowance for doubtful accounts to provide for any risk associated with bad debts on current receivables. Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such a contract additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied. Inventories – Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method. Inventories consist of raw materials. Property and Equipment – Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Valuation of Long-lived Assets – The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of March 31, 2016. Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of March 31, 2016. Research and Development – Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. Goodwill – Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in ASC 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events; such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods. Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. Stock-Based Compensation – Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. Basic and Diluted Earnings (loss) Per Share – Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings (loss) by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 21,720,103 shares of common stock. These common stock equivalents were not included in the computation of diluted loss as their effect would be anti-dilutive. Other convertible notes and options- related exercise prices were less than the average market price of the common stock. Concentrations and Credit Risk - The Company has a major customer who represents a significant portion of revenue, accounts receivable and notes receivable. During the three months ended March 31, 2016, the customer represented 28% of sales and represents 84% of accounts receivable and 100% of notes receivable at March 31, 2016. The Company has a strong relationship with this customer and does not believe this concentration poses a significant risk, as their products are based entirely on the Company's technologies. The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer. Recent Accounting Pronouncements - In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") 2016-02, “Leases.” This ASU requires lessees to put most leases on their balance sheets but recognize expenses in the income statement in a manner similar to current accounting treatment. This ASU changes the guidance on sale-leaseback transactions, initial direct costs and lease execution costs, and, for lessors, modifies the classification criteria and the accounting for sales-type and direct financing leases. For public business entities, this ASU is effective for annual periods beginning after December 15, 2018, and interim periods therein. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures. In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting.” This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2016, although early adoption is permitted. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 17 R7.htm IDEA: XBRL DOCUMENT

NOTES RECEIVABLE	3 Months Ended
NOTES RECEIVABLE	Mar. 31, 2016
NOTES RECEIVABLE [Abstract]
NOTES RECEIVABLE.	NOTE 2 – NOTES RECEIVABLE On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the managing member of R&D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&D Products and Mr. deGreef, specifically patented applications using Bend Sensor® technology that were filed jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor® applications for R&D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&D belong to Flexpoint and therefore is sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&D Products. On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $25,000 to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of 10% to be paid no later than December 31, 2015. The Company is currently evaluating actions it should take relative to this note receivable which is in default. On April 1, 2015, the Company paid $51,157 for the assumption and assignment of a convertible promissory note receivable issued by Bend Tech, LLC (“Bend Tech”; one of the Company's customers – see also Note 1, Concentrations and Credit Risk) and held by a third-party Bend Tech investor (“the Investor”). The note bears interest at the rate of 10% per annum and had a maturity date of April 1, 2015. The agreement allows the holder, at its option, to convert the note to a 5% ownership of Bend Tech. The Company elected to take assignment of those conversion rights, reaching an agreement with the Investor to pay the principal and interest to the Investor at the due date. Bend Tech is expected to become a more significant customer of the Company as it begins its product introductions, and the Company elected to pay off the note and put itself in position to either receive the payment plus interest or convert the note into ownership of Bend Tech rather than have an outside investor make such conversion. As of the date of this report, the note is in default and the Company has not exercised its conversion option.

XML 18 R8.htm IDEA: XBRL DOCUMENT

CONVERTIBLE NOTES PAYABLE	3 Months Ended
CONVERTIBLE NOTES PAYABLE	Mar. 31, 2016
CONVERTIBLE NOTES PAYABLE [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 3 – CONVERTIBLE NOTES PAYABLE Convertible Notes Payable During 2015, the Company secured additional financing to cover its ongoing operations in the amount of $590,000 by issuing various convertible notes bearing 10% annual interest (15% default interest), secured by business assets and carrying exercise prices ranging between $0.025 and $0.07 per share. Additionally during 2015, the Company issued $51,000 for a non-convertible note payable bearing 10% annual interest (15% default interest) and secured by the $51,157 note receivable held by the Company (see Note 2). During 2015, all of these notes (both convertible and non-convertible issued in 2014 and 2015) and accrued interest were either converted into common stock or extinguished and consolidated into two remaining convertible notes payable to two investors in principal amounts of $684,660 and $123,797 (with respective maturity dates of December 31, 2016 and November 30, 2016). Both notes are convertible at $0.05 per share, bear 10% annual interest rates (15% default interest) and are secured by business assets. On January 20, 2016, the Company entered into a promissory convertible note with Capital Communications LLC for up to $300,000 which is expected to be funded in tranches of $50,000 for each of the six months thereafter. Accordingly, on January 26, 2016, February 26, 2016 and March 31, 2016, the Company received proceeds for an aggregate total of $150,000 from Capital Communications LLC. The note has an annual interest rate of 10% and is secured by the Company's business equipment. The principal amount of the note, and all accrued interest is due and payable on or before December 31, 2016 and each note has a conversion feature for restricted common shares at $0.06 per share. At March 31, 2016, the Convertible Notes Payable principal is $998,457, the unamortized discount is $616,077 and interest accrued and unpaid is $49,217. The Company recorded interest expense of $198,275 during the three months ended March 31, 2016 as it amortized the discount charges generated by the issuance of convertible notes payable. Convertible Note Payable Related Party On August 8, 2011, the Company entered into a convertible note payable with a Company Director for $40,000. This note is due on December 31, 2015, bears an annual interest rate of 10% annual interest (15% default interest) and is secured by business equipment.

XML 19 R9.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS

3 Months Ended

Mar. 31, 2016

STOCK OPTION PLANS [Abstract]

STOCK OPTION PLANS

NOTE 4 – STOCK OPTION PLANS

On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated. This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company's trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent. The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares. The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.

On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company's common stock. Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees. Of the options issued, 640,000 have an option price of $0.14 per share, 900,000 have an option price of $0.15 per share, 595,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share. Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively. We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.

Market value at the time of issuance – Range of $0.14 to 2.07
Expected term – Range of 3.7 years to 10.0 years
Risk-free interest rate – Range of 1.60% to 4.93%
Dividend yield – 0%
Expected volatility – 200% to 424%
Weighted-average fair value - $0.16 to $2.07

A summary of all employee options outstanding and exercisable under the plan as of March 31, 2016, and changes during the three months then ended is set forth below:

Options	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at the beginning of period	2,185,000	$	0.16		9.66	$	--
Granted	--		--		--		--
Expired	--		--		--		--
Forfeited	--		--		--		--
Outstanding at the end of Period	2,185,000	$	0.16		9.41	$	--
Exercisable at the end of Period	1,755,000	$	0.15		9.41	$	--

XML 20 R10.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK	3 Months Ended
CAPITAL STOCK	Mar. 31, 2016
CAPITAL STOCK [Abstract]
CAPITAL STOCK	NOTE 5 – CAPITAL STOCK Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. At March 31, 2016 and December 31, 2015, there were no shares of preferred stock issued or outstanding. Common Stock – There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized. No shares of stock were issued during the three months ended March 31, 2016. On January 12, 2015, the Board of Directors approved the conversion of $165,000 in convertible notes held by Capital Communications LLC, plus $33,023 in interest accrued and unpaid, to 2,800,000 shares of restricted common stock at an average conversion price of $0.07 per share On January 20, 2015, the Board of Directors approved the conversion of $135,000 in convertible notes held by Empire Fund Managers, plus $23,760 in interest accrued and unpaid, to 2,650,000 shares of restricted common stock at an average conversion price of $0.06 per share. In October 2015, the Board of Directors approved the issuance of 3,400,000 shares of restricted common stock to extinguish $330,000 in accrued liabilities arising from investor relations services, at an average price of $0.084 per share. In November and December 2015, the Board of Directors approved the conversion of $470,000 in convertible notes to 9,400,000 shares of restricted common stock.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

+ Details

XML 21 R11.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Mar. 31, 2016
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 - COMMITMENTS AND CONTINGENCIES The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017. Either party may terminate the lease upon 90 day written notice. Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), and will pay $9,300 per month in 2016 and $9,600 per month in 2017. In September 2005 the Company entered into a manufacturing agreement with R&D Products, LLC, a Utah limited liability company, doing business in Midvale, Utah. For the purpose of this contract, management considers R&D Products to be a related party because a controlling member of R&D Products, LLC is also a non-controlling shareholder of Flexpoint Sensor Systems, Inc. R&D Products has developed a mattress with multiple air chambers that uses the Company's Bend Sensors® and the Company has entered into an agreement to manufacture the Bend Sensors® for R&D's specific mattress use. The initial order is for 30,000 Bend Sensors® to be used to begin manufacture of 1,000 mattresses. During 2007 and 2008 R&D Products deposited with Flexpoint the sum of $100,000 to begin work on the initial production order of 20 commercial beds. Additional revenue from this contract is dependent upon R&D Products selling either their bed technology directly or licensing their technology to a third party. On September 11, 2008 R&D Products, LLC entered into a long-term Licensing Agreement for their bed technology with a major medical solutions provider (Licensee). The Agreement provides the Licensee the exclusive world–wide rights to R&D's patented medical bed technology. On that same day the Company, R&D Products and the Licensee entered into a long-term joint manufacturing agreement for R&D's medical bed technology and related products. The manufacturing agreement allows for the Company to manufacture sensors for the bed technology and related medical products through 2018 with an option to renew each year thereafter. Production schedules with specific quantities and deadlines are still being outlined. (See Note 2). At this time management is unsure the effect their litigation with R&D will have on this agreement with R&D or its Licensee. The Company is currently evaluating actions it should take relative to the notes receivable referenced in Note 2, which are in default.

XML 22 R12.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	3 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2016
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS At March 31, 2016 and December 31, 2015, the Company had accounts payable of $3,035 and $322 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

XML 23 R13.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	3 Months Ended
SUBSEQUENT EVENTS	Mar. 31, 2016
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 8 - SUBSEQUENT EVENTS On April 29, 2016 the Company drew $50,000 against a convertible promissory note for up to $300,000 from a third party, the proceeds of which will be used to fund operating expenses. The note has an annual interest rate of 10% and is secured by the Company's equipment. The note has a conversion feature for restricted common shares at $.06 per share and a maturity date of December 31, 2016.

XML 24 R14.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	Mar. 31, 2016
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Condensed Consolidated Interim Financial Statements	Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2015 included in the Company's Form 10-K filed with the Securities and Exchange Commission on April 14, 2016. In particular, the Company's significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2016.
Nature of Operations	Nature of Operations – The Company is located near Salt Lake City, in Draper, Utah and is a company engaged principally in designing, engineering, and manufacturing sensor technology products and equipment using Bend Sensors® flexible potentiometer technology. The Company suffered losses of $469,375 and $478,687 and used cash in operating activities of $138,012 and $129,406 during the three months ended March 31, 2016 and 2015, respectively. Through March 31, 2016, the Company had an accumulated deficit of $24,439,002. These matters raise doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.
Cash and Cash Equivalents.	Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash and equivalents of $32,779 at March 31, 2016 and $22,706 at December 31, 2015 represent cash on deposit in various bank accounts with a financial institution.
Fair Value of Financial Instruments	Fair Value of Financial Instruments - The carrying amounts reported in the balance sheets for accounts receivable, accounts payable and accrued liabilities approximate fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates that approximate current market rates.
Accounts Receivable	Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided, including any shipping and handling fees, and are shown net of the allowance for bad debts. Due to the limited amount of transactions, collectability of the trade receivables is reasonably assured. While the Company has historically experienced very minimal bad debts it felt it prudent to create an allowance for doubtful accounts to provide for any risk associated with bad debts on current receivables. Most contracts associated with design and development engineering require a deposit of up to 50% of the quoted price of the initial phase of such contracts prior to the commencement of work. As the Company completes each phase or milestone of such a contract additional funding is normally required from the customer. These deposits are considered deferred income until each phase or milestone is completed and accepted by the customer, at which time the agreed upon price for that particular phase of the contract is billed to the customer and the deposit applied.
Inventories	Inventories – Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method. Inventories consist of raw materials.
Property and Equipment.	Property and Equipment – Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale, or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.
Valuation of Long-lived Assets	Valuation of Long-lived Assets – The carrying values of the Company's long-lived assets are reviewed for impairment quarterly and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. The Company's analysis did not indicate any impairment of assets as of March 31, 2016.
Intangible Assets	Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the rights to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology rights, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The Company's analysis did not indicate any impairment of intangible assets as of March 31, 2016.
Research and Development	Research and Development – Research and development costs are recognized as an expense during the period incurred until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.
Goodwill	Goodwill – Goodwill represents the excess of the Company's reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in ASC 360, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Company's targeted market conditions, as well as relevant entity-specific events; such as a change in the market for the Company's products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 360, management has determined that the value of Company's assets is not more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.
Revenue Recognition	Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.
Stock-Based Compensation	Stock-Based Compensation – Under ASC Topic 718, Stock Compensation, the Company is required to recognize the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.
Basic and Diluted Earnings (loss) Per Share	Basic and Diluted Earnings (loss) Per Share – Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings (loss) by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 21,720,103 shares of common stock. These common stock equivalents were not included in the computation of diluted loss as their effect would be anti-dilutive. Other convertible notes and options- related exercise prices were less than the average market price of the common stock.
Concentrations and Credit Risk	Concentrations and Credit Risk - The Company has a major customer who represents a significant portion of revenue, accounts receivable and notes receivable. During the three months ended March 31, 2016, the customer represented 28% of sales and represents 84% of accounts receivable and 100% of notes receivable at March 31, 2016. The Company has a strong relationship with this customer and does not believe this concentration poses a significant risk, as their products are based entirely on the Company's technologies. The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer.
Recent Accounting Pronouncements	Recent Accounting Pronouncements - In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") 2016-02, “Leases.” This ASU requires lessees to put most leases on their balance sheets but recognize expenses in the income statement in a manner similar to current accounting treatment. This ASU changes the guidance on sale-leaseback transactions, initial direct costs and lease execution costs, and, for lessors, modifies the classification criteria and the accounting for sales-type and direct financing leases. For public business entities, this ASU is effective for annual periods beginning after December 15, 2018, and interim periods therein. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures. In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting.” This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2016, although early adoption is permitted. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 25 R15.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS (Tables)

3 Months Ended

Mar. 31, 2016

STOCK OPTION PLANS [Abstract]

Schedule of Stock Option Activity

Options	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at the beginning of period	2,185,000	$	0.16		9.66	$	--
Granted	--		--		--		--
Expired	--		--		--		--
Forfeited	--		--		--		--
Outstanding at the end of Period	2,185,000	$	0.16		9.41	$	--
Exercisable at the end of Period	1,755,000	$	0.15		9.41	$	--

XML 26 R16.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014
Nature Of Business [Line Items]
Net loss	$ 469,375	$ 478,687
Cash used in operating activities	138,012	129,406
Accumulated deficit	24,439,002		$ 23,969,627
Cash and cash equivalents	32,779	$ 8,901	$ 22,706	$ 18,307
Goodwill impairment charge	$ 0
Anti-dilutive securities excluded from computation of earnings per share amount	21,720,103
Minimum [Member]
Nature Of Business [Line Items]
Intangible assets, useful lives	5 years
Maximum [Member]
Nature Of Business [Line Items]
Intangible assets, useful lives	15 years
Sales [Member] \| Customer One [Member]
Nature Of Business [Line Items]
Risk percentage	28.00%
Accounts Receivable [Member] \| Customer One [Member]
Nature Of Business [Line Items]
Risk percentage	84.00%
Notes Receivable [Member] \| Customer One [Member]
Nature Of Business [Line Items]
Risk percentage	100.00%

XML 27 R17.htm IDEA: XBRL DOCUMENT

NOTES RECEIVABLE (Details) - USD ($)		3 Months Ended
NOTES RECEIVABLE (Details) - USD ($)	Apr. 09, 2013	Mar. 31, 2016
Legal Proceedings [Line Items]
Payment for note receivable		$ 51,157
Interest rate		10.00%
Maturity date		Apr. 01, 2015
Conversion right, ownership percentage		5.00%
Notes Receivable One [Member] \| Settled Litigation [Member] \| R&D Products, LLC [Member]
Legal Proceedings [Line Items]
Interest rate	10.00%
Notes receivable	$ 25,000

XML 28 R18.htm IDEA: XBRL DOCUMENT

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)		3 Months Ended		12 Months Ended
CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	Jan. 20, 2016	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Debt Instrument [Line Items]
Proceeds from borrowings under convertible note payable		$ 150,000	$ 120,000
Convertible notes payable, principal amount outstanding		998,457
Accrued interest		49,217
Interest expense		198,275
Discount balance		616,077		$ 763,352
2015 Various Convertible Notes [Member]
Debt Instrument [Line Items]
Debt instrument, face amount				$ 590,000
Debt instrument, interest rate				10.00%
Debt instrument, default rate				15.00%
2015 Various Convertible Notes [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, conversion price				$ 0.025
2015 Various Convertible Notes [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, conversion price				$ 0.07
Notes Payable Third Parties [Member]
Debt Instrument [Line Items]
Debt instrument, face amount				$ 51,000
Debt instrument, issuance date				Apr. 01, 2015
Debt instrument, interest rate				10.00%
Debt instrument, default rate				15.00%
Debt instrument, collateral amount				$ 51,157
New Convertible Notes Payable One [Member]
Debt Instrument [Line Items]
Debt instrument, face amount				$ 684,660
Debt instrument, conversion price				$ 0.05
Debt instrument, maturity date				Dec. 31, 2016
Debt instrument, interest rate				10.00%
Debt instrument, default rate				15.00%
New Convertible Notes Payable Two [Member]
Debt Instrument [Line Items]
Debt instrument, face amount				$ 123,797
Debt instrument, conversion price				$ 0.05
Debt instrument, maturity date				Nov. 30, 2016
Debt instrument, interest rate				10.00%
Debt instrument, default rate				15.00%
The 2016 Capital Communication Notes [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 300,000
Debt instrument, conversion price	$ 0.06
Debt instrument, issuance date	Jan. 20, 2016
Debt instrument, maturity date	Dec. 31, 2016
Debt instrument, interest rate	10.00%
Proceeds from borrowings under convertible note payable		150,000
The 2016 Capital Communication Notes [Member] \| Debt Issuance, Each of Six Months After Issuance [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 50,000
Convertible Notes Payable to Related Party [Member]
Debt Instrument [Line Items]
Debt instrument, face amount		$ 40,000
Debt instrument, issuance date		Aug. 08, 2011
Debt instrument, maturity date		Dec. 31, 2015
Debt instrument, interest rate		10.00%
Debt instrument, default rate		15.00%

XML 29 R19.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS (Narrative) (Details) - USD ($)		3 Months Ended	120 Months Ended	124 Months Ended
STOCK OPTION PLANS (Narrative) (Details) - USD ($)	Aug. 24, 2015	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted during period
Option pricing assumptions
Weighted-average fair value of options granted
Stock-based compensation expense.			$ 2,398,185
Options outstanding		2,185,000	2,185,000	2,185,000
Unrecognized compensation cost related to employee stock options			$ 37,698	$ 37,698
2005 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Effective term		10 years
Shares authorized		2,500,000
2005 Stock Incentive Plan [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	2,185,000
Options granted during period				3,096,000
Exercise price of stock options granted, minimum				$ 0.14
Exercise price of stock options granted, maximum				$ 2.07
Option vesting period				3 years
Option expiration period				10 years
Option pricing assumptions
Dividend yield				0.00%
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Minimum [Member]
Option pricing assumptions
Market value per share at time of issuance			$ 0.14	$ 0.14
Expected term				3 years 8 months 12 days
Risk-free interest rate				1.60%
Expected volatility				200.00%
Weighted-average fair value of options granted				$ 0.16
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Maximum [Member]
Option pricing assumptions
Market value per share at time of issuance			$ 2.07	$ 2.07
Expected term				10 years
Risk-free interest rate				4.93%
Expected volatility				424.00%
Weighted-average fair value of options granted				$ 2.07
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	640,000
Exercise price of stock options granted	$ 0.14
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	900,000
Exercise price of stock options granted	$ 0.15
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	595,000
Exercise price of stock options granted	$ 0.20
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	50,000
Exercise price of stock options granted	$ 0.25
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	225,000
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	1,960,000

XML 30 R20.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Shares
Outstanding at the beginning of period	2,185,000
Granted
Expired
Forfeited
Outstanding at the end of Period	2,185,000	2,185,000
Exercisable at the end of the Period, shares	1,755,000
Weighted Average Exercise Price
Outstanding at the beginning of period	$ 0.16
Granted
Expired
Forfeited
Outstanding at the end of Period	$ 0.16	$ 0.16
Exercisable at the end of Period, weighted average exercise price	$ 0.15
Weighted Average Remaining Contractual Life (Years)
Outstanding at the beginning of period	9 years 4 months 28 days	9 years 7 months 28 days
Granted
Expired
Forfeited
Outstanding at the end of Period	9 years 4 months 28 days	9 years 7 months 28 days
Exercisable at the end of Period, weighted average remaining contractual life (years)	9 years 4 months 28 days
Aggregate Intrinsic Value
Outstanding at the beginning of period
Granted
Expired
Forfeited
Outstanding at the end of Period
Exercisable at the end of the Period, aggregate intrinsic value

XML 31 R21.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK (Details) - USD ($)	1 Months Ended	2 Months Ended	3 Months Ended
CAPITAL STOCK (Details) - USD ($)	Oct. 31, 2015	Dec. 31, 2015	Mar. 31, 2016
Debt Conversion [Line Items]
Preferred stock, shares authorized		1,000,000	1,000,000
Preferred stock, par value per share		$ 0.001	$ 0.001
Preferred stock, shares issued		0	0
Preferred stock, shares outstanding		0	0
Common stock, shares authorized		100,000,000	100,000,000
Common stock, par value per share		$ 0.001	$ 0.001
Total common shares issued during period			0
Restricted Stock [Member]
Debt Conversion [Line Items]
Conversion of convertible notes, amount		$ 470,000
Conversion of convertible notes, shares issued		9,400,000
Average conversion price for converted debt instruments	$ 0.084
Shares issued in settlement of accrued liabilities, shares	3,400,000
Accrued liabilities extinguished from issuance of restricted common stock	$ 330,000
The $1,125,000 [Member] \| Debt Conversion, January 20, 2015 [Member]
Debt Conversion [Line Items]
Debt conversion, date			Jan. 20, 2015
Conversion of convertible notes, amount			$ 135,000
Conversion of convertible notes, interest accrued and unpaid, amount			$ 23,760
Conversion of convertible notes, shares issued			2,650,000
Average conversion price for converted debt instruments			$ 0.06
The $1,125,000 [Member] \| Debt Conversion, January 12, 2015 [Member]
Debt Conversion [Line Items]
Debt conversion, date			Jan. 12, 2015
Conversion of convertible notes, amount			$ 165,000
Conversion of convertible notes, interest accrued and unpaid, amount			$ 33,023
Conversion of convertible notes, shares issued			2,800,000
Average conversion price for converted debt instruments			$ 0.07

XML 32 R22.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES (Details)	3 Months Ended
COMMITMENTS AND CONTINGENCIES (Details)	Mar. 31, 2016 USD ($)
Operating lease expiration period	Dec. 31, 2017
Lease, monthly payment in 2015	$ 8,950
Lease, monthly payment in 2016	9,300
Lease, monthly payment in 2017	9,600
Rand DProducts Llc [Member]
Deposit received from related party for commercial beds	$ 100,000

XML 33 R23.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Related Party Transaction [Line Items]
Accounts payable - related party	$ 3,035	$ 322
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Accounts payable - related party	$ 3,035	$ 322

XML 34 R24.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details) - Subsequent Event [Member] - Convertible Promissory Note [Member]	Apr. 29, 2016 USD ($) $ / shares
Subsequent Event [Line Items]
Debt instrument, issuance date	Apr. 29, 2016
Debt instrument, face amount	$ 50,000
Maximum borrowing capacity	$ 300,000
Debt instrument, interest rate	10.00%
Debt instrument, conversion price \| $ / shares	$ 0.06
Debt instrument, maturity date	Dec. 31, 2016

EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 37 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 54 172 1 false 32 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://www.flexpoint.com/role/flxt-daei Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.flexpoint.com/role/flxt-ccbs CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.flexpoint.com/role/flxt-ccbsp CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.flexpoint.com/role/flxt-ccsoo CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.flexpoint.com/role/flxt-ccsocf CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.flexpoint.com/role/flxt-sosap SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 6 false false R7.htm 00000007 - Disclosure - NOTES RECEIVABLE Notes http://www.flexpoint.com/role/NotesReceivable NOTES RECEIVABLE Notes 7 false false R8.htm 00000008 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://www.flexpoint.com/role/flxt-cnp CONVERTIBLE NOTES PAYABLE Notes 8 false false R9.htm 00000009 - Disclosure - STOCK OPTION PLANS Sheet http://www.flexpoint.com/role/flxt-sop STOCK OPTION PLANS Notes 9 false false R10.htm 00000010 - Disclosure - CAPITAL STOCK Sheet http://www.flexpoint.com/role/flxt-cs CAPITAL STOCK Notes 10 false false R11.htm 00000011 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.flexpoint.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.flexpoint.com/role/flxt-rpt RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.flexpoint.com/role/flxt-se SUBSEQUENT EVENTS Notes 13 false false R14.htm 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) Sheet http://www.flexpoint.com/role/flxt-sosapp SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) Policies 14 false false R15.htm 00000015 - Disclosure - STOCK OPTION PLANS (Tables) Sheet http://www.flexpoint.com/role/flxt-sopt STOCK OPTION PLANS (Tables) Tables http://www.flexpoint.com/role/flxt-sop 15 false false R16.htm 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.flexpoint.com/role/flxt-sosapd SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.flexpoint.com/role/flxt-sosapp 16 false false R17.htm 00000017 - Disclosure - NOTES RECEIVABLE (Details) Notes http://www.flexpoint.com/role/NotesReceivableDetails NOTES RECEIVABLE (Details) Details http://www.flexpoint.com/role/NotesReceivable 17 false false R18.htm 00000018 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) Notes http://www.flexpoint.com/role/ConvertibleNotesPayableDetails CONVERTIBLE NOTES PAYABLE (Details) Details http://www.flexpoint.com/role/flxt-cnp 18 false false R19.htm 00000019 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) Sheet http://www.flexpoint.com/role/flxt-sopnd STOCK OPTION PLANS (Narrative) (Details) Details http://www.flexpoint.com/role/flxt-sopt 19 false false R20.htm 00000020 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Sheet http://www.flexpoint.com/role/flxt-sopsosoad STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Details http://www.flexpoint.com/role/flxt-sopt 20 false false R21.htm 00000021 - Disclosure - CAPITAL STOCK (Details) Sheet http://www.flexpoint.com/role/CapitalStockDetails CAPITAL STOCK (Details) Details http://www.flexpoint.com/role/flxt-cs 21 false false R22.htm 00000022 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.flexpoint.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.flexpoint.com/role/CommitmentsAndContingencies 22 false false R23.htm 00000023 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.flexpoint.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.flexpoint.com/role/flxt-rpt 23 false false R24.htm 00000024 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.flexpoint.com/role/flxt-sed SUBSEQUENT EVENTS (Details) Details http://www.flexpoint.com/role/flxt-se 24 false false All Reports Book All Reports flxt-20160331.xml flxt-20160331.xsd flxt-20160331_cal.xml flxt-20160331_def.xml flxt-20160331_lab.xml flxt-20160331_pre.xml true true ZIP 41 0001548123-16-000596-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001548123-16-000596-xbrl.zip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�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

:1IOMBY%-1D/"21!3U(8X[ R/LK%,T..*T M9LUFK)JW.4V-C5N8R<&H?+]#95)'Y8M&H+9UC(] U/9S[5:E2_9;A5F6I$_\ M+!C0-7LZ$<7E>G(1U#O(=%ZYN4A/81%^YYA40?U,DOJ9D0P9>;F459P(MK^, M;+-3(TX.\Z$5 D6+\JXQ ,8:A#.(JF\5FPB9KN[$4]H:ALKV_7?[,N(J/$\O MO,.#'OARN^'@0S[,8GN;+=)0S##LSODZ7F^BY(G*3].""#16;.@%$*8Y(1YA MKI8PV#--,VK%9T=)% 4I"=:\3\F;2UFM?%8>++4)0LE6!/XR9-C)6.5GY/-] M0NZ#!\K*TY@$D4 %77IW5B0,4(E]E4MG_'2"[?FZ28&+.[MNM#0$M&+!>:U M_=[3JLQ+!)IA^A;C:6;CT)2-.OX 6#7&X"U-Y MICEEOU24;#0QM>03F /S!;%[HS9EHHY.&=1VY "F. MB-TI(EP3^9JW-?B_OO&BX0#!26)=E5)F:>3:Q)H0C;AM!I.A 4@4+089P@3V M/.HL(F/,T&+ 01E2>T%G ;^Y8+(V!&RLL:".:2\8;/K& A+8^C45RM]*_$X9 M77Q[ESQ\MZ0A^[W>_<#_P9L1/[QY^^Y-V9!@C_YV+.YJ_BN-HO^,D\_Q-0VR M)*9+/A_?:4B RY<_#:#\($J!_1D6N"%FU$PR2\^*UX2_?_,'+T"J$J0H,BV- MX-6>6-=,BT1&N3V)[,'EED*_)=&6-4/3IY,P8K%921U%N0YE.N60J**PCT61 MKGH(-=I2%25VSTGQPA!WRHO [P)&FZ!?KA-4Y:TKL0E:ZQW M<\WZ7ELUWO7%.[!7%4="O]X;+!(HK4"XH!"N*%&^)KOWI"C@"S4,]2UA" @A M7:+(Q61\ 6+*+6T$5P^#G-XEZ9.2+=)2'9*T2B%Q0VH;BQ)MY1 F-&4J HBG MI'KL"^SE%2=!NZZ&NR!OE)9A6P\%MY"^W-Y&X>(D2H+V1G9MF0Z<&V60P"RQ MBP7EIFH(D.L2%8R+9T0\] 7$LLJ20%A=IUT U\K*X*NK>K?@O:)W(=_C%^?G MP;J-)E.Q#H3;Q9!0++>.!>2.=@B66T(5G/>/"7_N"Z(5U2$<]J 7>DMHUO8OG M1+P@[(TO*%?5HJRQK:UP22N[65[:O#9@PS'2]]V<4VS_(@YK<'JV$/ M$.IR0"N$10B 9VCLT-L"446G8L>;8G&4*'50G :3D5I!;V@$086,4W T20BF M$9:RS0:%KJAW5,ZZGX39(HA^IT%ZPI[(!H$,)6LD4Y8= T8<.$NF2'"\5+/]D@JUT-']1@4#.B)J/CA X[KEEQP]1JB%!_+<%^ M\1H-[G5K> @OM<) +0KO<XC=J08E527S)X\F)R1$IKU!:$JR"[%1^Y MS=[G)Z>'\_,;,C\\O/CU_.;T_!=R M>7%V>GAZ?.W-B8\6>$CL:ZQ%);/@GEP]<#-K_FT<(R8%HF"KEE.VI$I/4@[X*E?9]/0$'AGX&9OMG(G=Z M<<83*C15T0,#\(KXTDNU,@+AT&C\&+5W2KIS EI<$5NZQ5'CALH;W)@@L0+G M>T=X5KTA-5+[L5H87-E*MAK@H6)B6TS-,B.@QF=0N]:46_+\8HJB6I4\T<) Q9*FD)HC!MA,F6/.:0[CB4[$ MF&OJ(H[R3=K;*85E2?TQ2B+C*8#%E M2@C4#'E3JL*816% '96]Z98NS\+@-HQ"$&7UY;L\597'(J?>'S1&*LV :*B0 MGI6O2+1_YPW=#!4MXQ@(&Q)BR>6D; +":50*;==;0>LC?G#!(A3'%;!_1U1< MG1$OYVN^3^(?XOEERD_:S9_X!M6BP^HWXM&OVQ MO )%"QQCL^J5:&GOGA_PHZ K"ZQ1OC?A3>3!!;PL4+F@E"2NH9B1AL&72%K@ MP2 _%[2-Q2U#R[/1V&LX3L2!N=D9S;*_D/DK7Y'Q]6P9V_-83:26SG(90,./ \*RFE1,RK?2*J8"(Z>1/^;\73#.C-&O&L#"65"I9?Z32^1=? M@II#'DDBHG/6=L,IODE9+!XA1HP8R*O#J>57I!X_\G^V0U,_X7:P!0KCA$\K M3Y$"(M0F(,3!5!4'.Y9WJ"_J=ZW3HL3$9X?VQ$TWN/3!72=<@)1( D _W(Y+ M:3%)?9*D1\GV-E]MH^X\JV%*I(\."<$M=*#QW-IO/+K;F(:Q'JY1OG!!L6+! MGSA@CS)I..@+5EE4 .N2!X?^F!\Q1M3&92Y6_&Y-?K$B=_,RI>MPNU;%!:A< M.Q:8Y7#X#_4/B?, &[7,ZD7X:J-E68"P/_G%4IXM^0.CI,ME2X!U^&N2 MEW#6%VS:G2%NO$+;SBX"3/G@?@.H9:OSY8/2/ CO );3#ILWO#N- M;DX7]W$2)7>^K(># <1 4 .P]-QL"YN(.0D@1\D44J-#L?F<<@06_BRSPU $ M3IL7XCQT^5/C!UM[,,CFX<[F-^)U+.0G()$#Y0+,VXFC>5'I+M%+%X4V@BG/EB MD+34Q?,D+;7Q:YE(QO65MT%Z$IY0"="-8@[XU0EUD$=$)?4<,FR)RFV;" MI87:@:Q5""9I39Q8PR5M.$#8DRYAQ45\#X M!%?S3)ZF/N705<_$N:YVA_&I;L&R_O?1JOIE_(M:=C QC 8$/R):*"VOJ*L M+L(Y:?DK_' 0\7KT ]J2,^^1#^TPV-) ]R5])K **D "ZY$&(W!+!Y3 $P+5KN^R$:?$ M'\> ;8A04Z8VWQFISCI_LL!LK'7Y!+*DEZ62S"_MP?S=1ZD M.1:^^:6$7]G\:+E 89/:+%?^WZ2EH5 ML"Z30H7+GI/6:Z<=*)7EWOTHN4)U%#BH[K:I9,C7E=0W/H<" ]*@'2X(7H'] M+JDJV=@ 7_KQ5=TYS"Y /^F@^N%] M2%?'CW0AUOYDMU;4K[V M[.A^2/UWJ0D&38>':DD)[2R0-B+'DO4Z+,X\X#$A$9<)T9A?):3BF%FBS3&= M! ['S#XA<4QK", QC?RL]K(8JZN_]F6H'5#[78:!(=-AF%I2PC +G'G!,+[K M*TJR;4J-LV&]E,!Y*%7BFIH:SYVS56Y[$(%E*F>'%Q\_GMY\/#Z_N2;S\R-R M>"'NNCL^YQ?=>4]I';9L6&[&J 7Q) M,318K5BQTZ@/#-[=@-D/8?U"!'!-C)6NG@'"AS4TS,\D%J<_:2?;%<4D+&\6 M0R.RS#H>5UO:871L",V*)R3CC\@;\J>WW[Y]^XY?&4(>>(%_)>_>OCUX6_RO MV"'&FN';_#Y)PW_0Y;^2/[\[^.G]GP_>O?MA]Y8UTKM/PRSC5R3PE\DVSW+V M#P8M?W@LA8F4JAI R=A8+RXGG!9ZDW!*[!'+3D65F:DE*ZUF6+,T-M%DOJ#S MK67$BG8-V0;[#II4\8X:TFK6,42#"PU1ZE):OFB!-"%MYKOH"*5.5\)$G[J$ M&PIU?7)$HX:A'E2JRI-74DMC4,_F(3D&-02LJ*O6T*+EK5^X/'/".E$:@Z,@) M1)F&I"H-6K*"(3IA7KS8-_NAB5$B8LJ,#1$WJ5'BE:/$ MDE:XZI)2+RXCIB4B)Z3F84J78<[_=47#.-NF/!!#":H5-M%4(>R&K%I/'5%6 M9;,'<>6JFO0M)G6*DH+*GO)6#QHS>R&@,W)8J@3 9!AH)^3S)4WY@^".OH.R M6")BXFY#Q UC)5XYXFG34@]VUA7,1!+=[)YX2D)9G9NIIT:*D7 U40#-=/B: MLAW[M,OD\\=0O&HMQ.E_0R*8P N*95'96>R%N MU\JJZ[4.R&TQ?NH-H[2U+2,3 !X2'LFDI!0"X6ER]NA/E84)P;B$>P IS#.G MS+(YF=:@0L:-II6E*MB M+8D" M;(T/./"6&S"#7"8WXP_)_BGY))Y[,M*@J\X.\,UUWX:_1*)+ @A0QJ7":9SE MZ9;W/\_"F)ZRKJAJ%,]06D():6DT6FA\P:.&W B,'C+9@B+[-^03?T?$2X]X MHJMG*5?,P)#Q12(EYPP$25.ED(LTO OC(.)/BQNJ5!--8#EM>I'*.4@V&O]< MI!ZY.=M$)-,RJV4DU@Y;M+LS!U[='@<'B2%IF?&E3V$2>5-"@T!S*IJ6_2JZ MW,>2^EXL&&>A2K0$-BMQP&:HYRZH#;!MRW.CRMEU8P=O>8VD*@XLF7(?Z0_& MFR$66.)6'QA,RDQ1PDO\.[JKN8<3V%3X&R0#>KB)=QHF&-?!C\N%20]M;+:\ M:P.3'VA,5R&?OMQ_R0D-\JUR2^,05=J>)525@VZGW5>XZ)."/;#ML (5S_8O MZ\EU5;SV)XST1IZAK]L+Q_J.,$REJ9?/B9QSL]V_YT&JB/2,53:CE1I58[3;P=\U4BC6'I/$#KR.@-%'MXWNP]$ M^O4G% Q&IGU/'HYWZUZ]1G6//KX-BZ8*49V)/&WT44W[&4L[B!D=7UR$@S/K M^6"9;'?)Q)F/\\&Z>C;05 4,/0//]//!$"1-U9DU+2E2E-1V5K&7%"E\<-$9 MM5M2U):;72_NZ7(;43YN?9;$=V]RFJY):Q5%YM]*(U4M&[J8T)5&+0E3%]*' ME4;:A&BS<,(L;MNH=;F,PNSM2(W5_HLJ-,H:B\/Y+&JUF**:9'HVLTF6JRO M(+1N:0+76EC >*I,6&_EPH9SI1+:S-B2<) AI3ZYR)1M0[89LRG?':8-R_>> M]1--M6_(F#K(Z#-G0]*40?4XFRJ3G@=KJCU"RE18!"J/I%L-%$6L)ID%4=+J R][D M0H8%;FTA)TO9Y)ZY6;36L66_/*VEHMO96>R*>+>[ P (X[HS+9#T":HM;%Y+ M9@#@5)V?#T^_QN'?M_2(9HLTW/ #80QM.;"LMENDE'701S+XZ:+#I#9IVWM2 M:>I,>M4*>-=LA&/&T+>"04[?T5+H,/6ZH(CU8&GYWNG+-%P APT!\M!%Y%UY MMRO'5?XZ7BXN,3M@C7A'6VO#"=]DLC\TIK92?,.+^W:KCCVVX,O$#? T96ZE M'HL%X5,CW.%.*[A]1+#_33;6WL;XEX=LT$8JU]CV:/M4?14W**G)!, [&IQO M9'"9IUIVAFQ;,.U6\)&7THJWV)I@Q;NZH,U&!&]X!9H"TQ7704 RK:F" M@U'/:9TBXXHK&T!/Q?M?8Q:Y6=_S'W1Y5!Z"?)G2=;A=GU-8,@5IT#+?H,$! M]4$^N^"^R; M^?7Z="=?5T=>^Q@"8) RQ ;7.J#@%:3*0IX!NY1!B_-'J#B M7 Q@5B>X>W5SPMBPMARS= ?LB<)QG&YPV,GX$A.LP24)"3T!VHT'4$6R<- ;Y!/&@E^29/DYC"+F'VN@,SCRQE'Q M"AH- "I,\4"KPDU$ 'CM*";H+?>("CJ%LTO6T^([:CGU-PR1:4CS('TB.5W< MQTF4W#UY&@<@L#)' C@XC;% HPH0#6P@/F$\T'5SU45-_,9LVZN]<,17>%=4 M(BC/R^?%/4N_!=&VN-%S'D7)9Y\:ZIJZ-I,.TJ/LB@!(Y!9'=IW!/,F#"-(5 M5!CJ!RC>N>._51=6+P4Y@$Y;7^SXU0V[8*U#QO[X[BS)LL,@39]62?HY2)?@ MEI=9@RDPZS2XX9G99T=A7&NX!QDU^F:[=R1B+\F"OR75:T^)"@"3F;]@1!I) MK=8$X+H%K*?L>Z7,.W OJU[8V)\J"COJ.=4]<=5'*FWTZ0T)47F[2[SSE'_- M"@;T;"2 ,/=AN!"DM^(<0.,TMO:F^B*)-[ANN'5)D^M%04DM4^J#L#/@=9 M+0KKW'AQ)G++K=T QVY\ \HVM:2)=#))-]Q3^^B(@E*#/9@HT2-O+SV? 2H- M7LPT-8+-R-:N!@!IIT0JL/GU'3]N:)S1PV3-_ULX'2^+^W+R3%S#]2'(Z+)>@-]B#DU)B*9, M.0S%E)M0@O@K.,J2.![VB% 8AN5YF/][]Z+4?4#JPF)^M])_0(2%-[?<1+,8 M-^)I@,3DESFBXK/9&( 13 (B]LN.')LF8>^7 !H/2EGV+9G&JOGBGJ:4JCA3R]-Y@-7F45B#Q1B$\ M$_%96B6%W98R+W@4;)AN6PW9K4 MJ_#N/L\^TO4M5=^6!Y+JX-L@A01YD&]8+# 9@Q!#KV-V65LZO"]#/A7OO3DK M @8)":-LL-0EF59:QCL[$(Y(Q9 %!*9;SSQIH3;16H5P>"6UC$2CMFX :YHB ML^IOWV@AKZ\N"W3UV@%]H[ $X_KZ'Q/2U;'3%ZMZ1^>*\F-PE[R_4^L*709/ M?(M.9CQ%'4=KAS0#M2*Q#.7;L&@YU!D(CX?9F%W?7!S^)[FXO#F].">79_/S M:U^8CX-22:C A'\WM@S2+@M&N+P:+WH=!VD3-$)*-6* M/D8IE.@"] TG>IB-F:.#2<>,@29#E=M6ANDN[2U!>1TM!00F,?+$@! 6BJD#+3L2#FAI<(W-[3L&K.G M95N'A)9\-X XG9KE@'42^TQ)%32,E-1CRD3)EK29DB8PCDC)U8IU.,('>AHO MDC6]"1[Y25.'29R'\9:Y7.X)2>*L?'5%>;V$43'^95@.C*R]37$L[3BA /=; MD4(&FE. T()D:[931$*A2:QVYB?-D;0AXA,E3Y2*Q0$7XN80[5"?L7P[D*G+XX0FDS](P49C!A ^E-+%H@Q2/,L\ M&R8TUW67ST!X=!BJDI-P#HRH"5A$TX=P0>4+*<[Y88,9:Q/-Q<93L8>LO=#B M/,E_ISF/$GLFQQ$^^-TLV*L7Q' MK&1;00HHBQ*(K/S$"390D^: M,TX\7$1F'*C[3;E:S=*^1).\T.-)WPT =S M[1 TM&E>3_(CDCE, YS>A8^T,[9EO/%8KO>BG;\O#@?6[= N;^B-LE[*,)A M?.\O0*)_'_N 6&"OMG'RK'SYZ $)]L(DJ$E[$C'ZP[$;/H9"NQ-+K!5* LOS MH8FCC7\]'7'!&+YIK_:*S%_YH$" 5XR8=+./B*&A5(N3O_O0O[WXZ^)/?V>^\C@O;@7RL( M6O!<>A2P!]!U+S"L>HZKF'^-L[C'Y*S@^(DB@^SXRP/UT6[OYJH:?8 :*'4DS6B M8Y'+)C@[8+5%$,>P;A7LG803+Y+"61C3TYRN58O?;$3AX;DFZCK&=KQT'BCK M%@=%N[VB65'JC2A&]N7*XPK))UZ4B+*>K!JPPHU-Y%&ASB)\[%18Q0 U9KT@ M\L?@OY/T, JR[#Q8TZ-D'80]YOQT6N#TEFMQS72=[\Y)KS ^B/]2G890<$"$ M%!%BA,N13X6D_X%!"SZ;& % L46XD&FSBAP@.G@11'3W(T'%X&$"\\H;J'?. M P'\'B6CDEEQW!*+=0G)JDM][TD.NHFK%^KL M)GI[#=WY<4^7VL%?,[K:1F?ARGZ.MRL*)G-=U#&5NUZZ)G+#XA :UQ3-:K0- MRI[V5KPF$9/TGL02K%A06(DT.('W*FSHJ\&I#^15S@)_3O!6;.QU#5^OP75- MM5IC_QV3K=40+CA9J<$T\W4:?_8]#D!0AK%*HP-:A#4:GQ.4%1H2#O@:2^:K MG*;<:3Z[B!)1I!H'Q966Q@FBB_2;IH@Q;4>P(TU3_^SFGJ8TX,^>8]21(W%@ M[-'!>U@$:F@>&H?TG/$U&IW3Q_SF,XT>Z,ZWB#2 T M;K9R 4_)EBM7 'T/ NC/!4!CL?A[B0'1]T@0??\*T7T=C@G1]U.V<))D^3F, M(E5#IO6ZW5[9O<;A6,L:4NMCKQ5 DZKPK/J7)ZAO5T07W/*JZB"X+"8!JJHR MQT?C/.XNF"I?:<\*LY97X!D@CPIXL+^XC("8A5/&K&W'*7&Z@60%-+#%S1>MO_NF^#T>N")3J7'=0#0^^\\\2G-#XH""JVS3N[S/B@8 MX&43'$!(M0@1B\"QOYH7]/5D/V4P$.%5(GK.*'QW'F0D-L>%"%D M*F>_7%P<_?7T[(S,SX_(Z?G-_/R7TP]GQV1^?7U\X\E]LSW!91,HS""UB!(2 M958A @+V\>/#Z7H3A"D?3#I3;Z#3%U;PO5T8E==R3W#YV[$!YVE+=-]O#7)64TC-H1$!Y&9R2&VJ+Y+JW<"7C25PEZ\?FGSM MS.V3A&&K5"\=?5IFR!NG>OD]8KO,:AN5G4;#Z"79BWAWDTH_M/5KJ@$W7%GI MZME0\V#[U3YL7:3,L4V2!='%ZBR)[\1RJ*KWN8BV_/ F>3=4/2 ^31AH17:_H-&RY,D_353;82SDM6$ M 8TL.OV-?N+37F?2CNYJ32V:1_M6B:\T-P-&2V\HWG2T5NK0TQD.UQ%I'"^2 M-;W.@YQR)PVC,(;2;:JJ2N.04^\+$AV51@ $5,C.#B_.CX[/KX^/"/O7]<79 MZ='\AOUQ?V9-*.CR#P2;#N/D4A*. 7$V M-JMN@D?P^"9 0LHNA00BP[0^8;),90C*-+G\K'A)V%N?1QPA]:_@%00T:%U2O/0LEP_&KCCA8W% & MIMX&-/$+CW<3A+ERM_<'&M-5:&Q&R$NK E*[-&Z4D?N"'#HZ1BSB04NVWF0H M7Y&ORY??>,9Q13VKB:L%AI*-32D-Q<9$DI.+(W6V>D.*KV.Y3).',./Y8I6D M9 \Q7TXDQ(*4<27+4%!-NI9%TA8V3C0#1,Q]._2I7X!7SGIWEI.Q.@6ST_/# MBX_'Y&;^?XX]6>D+JG!(9PX\JZD1!77GO)AGK-RBV640+DUD:I92\:YK.E_^]S7(^A*E:F&XI#1M_Z$J['&10^>IT)$%BM/=P04?73#SQC&! M@$ [^ :$ 7OQ;2W@KKH1HI,36-%6G>/L@M1R"'V8 % M@[XV7(:,8=_M-+#T=JUW^.EI<<8',X*<9-5KDO++=+_^_H?_W[ 8;"?+7"P1*+PY"%53.C.X^49LQS56G!V0=.D!186U5I"H M F; Y''C/(F7=+E=Y'SA9!D#[6*&3@,L7L@UN(P5.I^=Q@F%X=XQ0JIOQIZ^ MV3\FM'CNV["&!8R@80" 16 (D&D"TQ\$Z%&IG](@HT>T^.]I/%\L^)VK&7.; MA@\!\U+->;!HE^P 42R6@[U$HS?$(HC79D6SJA3YNBKW#5]5414E^[+>^@OV#0.>OET[@ZHZ1<'5,@,KR.H3CWWJW#P M,GCJE7%:E?[DBWK'$3!K>LDY6'NH%-L"@D@W1$ MW3%5X:7#/-*UV).D;46:;,*+DEI9C_FK@@V,PGK0@3C<4@&D\720'3._R$SC MH+?,,@*HT9<'U'[I!@6J_B6=>DJ\HA'O8%\&J6W^,6NQ[L X+9[XRF45&@#LU0/)S-:6/(2?)@Q.R<>+#4T#?E_@8; )\R R M'[EAJ<#(4+4"1U0U>>R*LQJ[?,@J-6?3R\7;3UZ:?WQ MYED/[#S):6UU2,_A3) 68SXP:''$4Y#OKG*&R7@? NMUJO**D*JM&7PVPYDP M[ $B@@V(S1%"JPT2,SQDPVAYS.P%.C%XKBLXX/]RQ'$@WR,MN@6]9ZGS,J7\ MH(AJ/*=:]'#!F=0&V7&1 I3YBB"V'R)J[0*]*%/$ &I5B794GAW M)AH??Q%R?MU@,@R=@+C3 ^WFX -1"HE!WK-GM#0,=L85D7A2/J*;) O+P^7I,RDRDA*ZEL'14D7J:'N@Y-6 M0FG .B$N>>1&1KU:,H.DDHWY :<[X ME!EKM(6I.!;R*,CI.P5A=$5;9)$712&*S@LH@;,/!K$4O?B4[N674_IBGUFE.-]R.UP$.5.O&R29HO4\ZR53S8QXO MKW/6K[U/HB5-L^._;\/\"=X& (FK0YQ!')L:(&_1@Z/)JA67],IF9Z?S#Z=G MIS>GQ]=D?GY$KF\N#O_S/R[.CHZOKO^9'/_O7T]O?O>.>3 0Z6AI T,-8[5J MM'2V [(_3._)$[,'HG1XS(9A<&-!I%8>UT\?QY<[<_1@=RTY^1($'3="%,; M'8Y%:7--8+)>]I^_$(3:M/B0,#IQVS"F%ZO#E"[#_"3@]^GD3Q^#QW"]77]( MTC3Y7!RGPMYHLH>]BDXFL5&!1&E[K[$RC)5E",,M%,YX:7YQ75&>5 ('I!0A M.QE2"?E"^AXXDP2 WFCMA@*X*EE8\!KSEBF-13/ _@%K!W#!SU-=A?+;'X.5NI16 M($Q5",_V;PA_13X5+_[+%T8:*EK"/A TNCR3B\DX!0335.R9/X;J21%502UC MBH(.N%+WP 5+2OVV_!!B76;PQU[RHE&1!D9(*EW/!2Y@8H$4(%/@7UQ@G@%S MAZRPD@?-PLA6#1M.-$3KO"A>>)LSI!6LX8<&$&J.U(5T/-$":#JN M@+)%MZB!)TXR1M<+-QSID35J@C)^>)DY))5JY(95]MB+F'DQ=09)@C@39W3= MI,%R=\#'_L"N["C,%E&2;5-J6CX_2%>;5_UTX1!OR'<@,;.G"P#J]M(\.[^X M.;XF5\>'QZ>_S3^<'7NRQWL8Y+JL1T!P)RSTT2F)&RB$&"^P? S^.TD/MUF> MK&FJ2[;J@JV0("N(PG>U!SADENHW,U4B-JO^]"JS:FJPPS!C;;?ITQ7H<@. MC#&!+X89/]+U+4V5F)>4Z<"]408)Z1*[6"!OJH;@NRZQ&R/_5#SP!MNRFI+ M6EVA7437RLK K*OW$7$;7'8Q4F4?,X( M)Q;9%2;[TI[!@K5 2-8;S8?)P4NSK;CA[F,3LP98]*_?_ M)K%J$ %'*2S,@)6Z##F67^8T_,!]Z1V*H"9F3)Z(T%1I(+=/Y&NNA(3Q-V2G MIQ:E#LA>%=GK\CIVV0(;&L?Z$088TX#*P?'M.1'1R6)]!)=<,U)(8#8O+)7"FA=@I2ZCFN67.6U>P'WI'6$+;&B\ZT<88+0#*@='N^=$Q#&;%S8NN6:DM'DA8^$KW?";%Q,1 M3M*\F(1R[T&4LSV!'\$IYZ1[7P[_;4O")3O"!:^$LX+.\R#<^VG;\\5!CV=) MIFF>=\MT6]OU,E@!I&L7K2W<4 WB=$U"9,6(_1J6;"L^*I!=/:LJQ[2(@%7/F9[H:;56?IOV; %P/N7P'U(AH0#8.+\ M!1Q*ZS=[#E#4>UIKG-ESP!>,/7V%,7NN4]N9/9>-B/L]>P[!W8!A\&&SYQJ% M0P:[_9T]E[3D^X43@*+>P]CCA!/ %XP]7(T13G1J.^%$-@+F=SB!X&Y +WQ8 M.-$H'-+7]C><2%8.#9\MLU3:>\W?^(/TEE\V]EI [-DRJ G3;)ELR>!SG"VS M!?: 185XLV5 Y4,6&WI+Q#%GRVQ<"\@N,]C=?'W5=)H1MFJ0XE4_[[&:"M;6(:'(4NF, M[U6/<[*7(DTQ7R).3Z!)8LP@R'9CBITZ6109"/X1HP:K*!;P]H,P\7(7[$YS MNC8.;]C*M^,$7!XG0-CZBQ09+,P"0@)8V^QZN]E$ GI!1/8G5Y D)J66VI@H M/Q?:) M*X**$OXTM8"P@),0WK32RUM0THNF5$ZSR^")GQQ7WFZJI**R9(=\DI)(=%/Z M@$4PF0$(I;IRL\.$-:+3/&3/2,P+D)3R,SQ$5V:5,X(M1(DL3.(#?M][M,W" M!W$_2A!%A/\N&?]C4=.SI+>Y+QQ4XT'".A-XNCSK2,B894;:R%S:'\2H/3%+ M6U;&IVY9/$:I_$#DE,0$D%4=R9EX3/;//3MB2U^UGRG8X7K2(R.NR*X+&@9141_'O-0,Q7 B74BS\]0G>[@N2@EE>C%,ME M406$W56VDXNF.@;L:IWW?KM-AU"\%&UQW@8@RS 3(_BL31&%]*'8@"7>T$?> MT-R&V3T?5GVNJ 'TB:&XF;CGNV^BW"0?@OB/S-PPT)77-+9;Y=&;W%)_\!O> M;3-VS>^F=!E!RW<^MA2T=:UM2.O@H6M.-^3TC6H]HD9FT3Q>BM//]RT:OAS" MW&F%R,E8I9?#8Q?$/T26&+@JR+%R%= D?!@5JT+38C!K0VW! G_%;=6;#=NT\DSY)'VI3 MM@+?\$X3%V9/4E_NWNT#+&WST Z=N@:C09.^"6D+\PTX&X]GNRUOU22R M8=+?6+[%+TUY%&X9_<'AE/!1@1MN MDSS#$&H!&.,X0!_(3-K/WWG#S_TY#-+T:96DGX-TF3'WPF([W!%K'9FB)U!< M%52-XKBL GJ+'(+-5BVH9U(FU@7O%Y_STZW(HE[^@-"=!%DR$=_X"864FK9V MH%1RV:!&0W%;6/O >VNF6W/;.9O'XN] QGXU.Z%+]C(263++.99B!6M))>0[ M2?O0LC<1;:@W(=DN6Q]ODGFB[]OPY2VYJZ4T(:)==!N$D,B ,P[ M+$X8K4%H8E R*TOPK"&F=+P;) 9C0L(K*S1UJ:87E['/$H<3$K(UL@TEI$+, M1,B.F!M"*KQS1,BNM1Z$;"NI""E:+&49TEZ>[RDS5> P,U,/*R,S6^( 9DX# M2.#8G.W)UB"SP[')Q^Z>7[I Z5Q2 \?EI,.^'6<.XUS!B"^^&.>9317]?_! M//,-RJ\*4:)96K K/16$UHA4 M&!'33!=-4[J\SI/%'Y=!>I%>\YFDY6]!M*67-+V^#U+E0)"5<)L#0&$<;EAY MBL09J$T EV"J9KMR).,%#_BZ>_+ RY -34G&2WG".COH=-G8!WH=EH*42-C; M#[I3L5IX!:)PHZ26KV5)!^1L^.""B94!6]H5 M';Q]^Y;_KZ!<1H)M?I^DX3_H\E])G%1/R[,&6)\GV>89:ZN8)"1/-Y(B;BE."X>7!!R!JR02T#&L*."":S",7?&O9L:5=0[R;X1I4 M\I$[THHW4$@#%CV3ZH(F0FD!-BVOYKMP:<&MKA" 7W4A9QSK>N:.9PU;_;A6 M4Z'DVSZA^)FF:?&;A/"/;>+D["GI_6DEU6(DOU#3#0D))*):Z5%1*RB@X M(0"='"!JLC<(B6)=PRL6957H&(W3+G&H^54[&>0)F M4(IIDT!5!)Z/**_QT M(+%DQ\*.@A8)=2=4>7/%&0@16NX9<*2C7EM4SSTC^J:A7OUD+ #M9,4UE&L6 M1Z>;S!M\JK6LV-&L(6S*GR8+A@EV1&02RZ 3U$(Y[9'HB")C6SZ\4]76XC<;]-5;XX M2*4J[ T'H2"1L=$.8!)>&A1(&6H+3@^X"KONVU8NN8PWVN\P8K MF\DY_*WG) ;?VMT3>6!"&V_I[HU=#\AM..$1+ >E,_*)CV#_'!/8Z@1(LY8= M90^(*-1D+OE4%?1E!308)7#R D^)-,I;T-6#4R.5OIU3:XK61*#L%")NB5GS MRC$G"TL#Z,@5*)+G07%0THH$B\5VO2U&@)9TD])%6)QHQM[]Z<=_^>G@^Y]_ M$*+5'YXSM@X:.%F[4 /SE!\3!Z?H. !U PI%97<3_+#EMOU$&F!)!P M-_6DP$/(KY\]2=*C9'N;K[;1?"'NE5/N@P2(=/."1@2+=D:OT/*"SA*(;6H% MLP_!LKK%3ZPH\(9AYDJ7,0P*%0F_E*)2?L$!-AZ[KA@0]+< 2TJTN-,H@4(5 MB4T<9C05FXE0+S\3?WBV U-6.QV0JZNPC>E:R2Z$=?4\,F(UF^ [[V5H1=S^ MWK&'B%3PQO=]Z0JE'NUX[]:('*& O>Z[<@IT3KS+?7_0T TSI=WKKBO:1JRT M* YX-5X@X5AN 0!IF>"L?J.Z7X%85Y]=O)MKOP-]B8B$!>-BQ%S",/;W^T)BT9[=WR'3;DJ:D,E9BW["D\0$[4MK=JB23FYU?W!Q?DZOC MP^/3W^8?SHZ]&SC75:F&%= KE"02.D;X<&U2?37831K$&7.']1>SHS!;1$FV M3:EI(KJ'A@Y]+#0@T'-Z<7[M"SOMD21A;5\X=MD,UB1C>7],3\[^LS"FISE=*WN[0#$8SVMB+LG= M\M-XKV16EB"B"*F5(9]X*2**>9-E@?" DE<%+"!C=^)@FJHA.3DW MLP]/]3>Z,2EK!<"\+%/@-"VK/7:;E:5V^R=EB;H6K[T:0+.'#S@9&R$(S<5= M1?!4#(#Q-&PW#.&I"FK8BSPDH_( GXU60W<=L3:[/!N[4U:DED? <;NV@)X7 MDQ]KJ2*I<8P&)@;,;.BC-S#OW&8QRW$=@Q)-+]+#X1X@.L")"SP0I!>')RDO MAH@RRG[T^WF\/*(/-$K$"IWR8 ^*K0Y]V->4M.%@)>F>B4T?1^#C MSN! 5I9ZFMRL%7L&G&SAPXZ94G!9\;/08,E2!3)'Y6J>AHN\/)M,O[9-5[;+ M1UE9+ :J_4#CG-0$B&42R=G^,1'//;LJ5E^U,BH9D2 A3U=&2A< <,8D2,XZ MF'1Y'*0Q/VA@OM_'<417X2)4]_"@@AWJF 61> 3U$(M4 'L0AAG5S.:-W3;B MH2]$ Z-"PCI+1'4I:%(@XZ,W:'1T_QC0, 8P^=Z;+Q2:@&59+L Y\9*M!QIO MZ15=)'=QR(=%8$<-L#L).DY996834ROA"32@@),RT MPU*7E@9Y&2MM83@Z)=53S\W7'=$LO(L/R&$2%T.] M? 3@AK7&^9'693&OV*"=OI56HP+;TJE7146/A]1KFC.GEV>,0'=BI[BV;VXH MW<*QLC0*K V^X*!<;<0,>I7LK'Q!]F\\ZZ>;JKG#!!@NVL102'5Y @72B+3A MI^O?!AE='B9K/L8FW)JG*=_PQ$?>/CSMBY1WV,X_!^GR) A3=*-?F-QLQ- G1F6Q.#QXL$S".,7Q7?4KE?Y*PWO[MDGS1]H&MRQ;@E?,<2> M5PW=;1#QKWV/'=^'>X(5^(=X,FU&&/X;3IPJ!GV PQPRP*]9_:ZC("?Y/26W M]"Z,>6E^G-6&IF'BR6UM4[(7+QVAA1*T/-7?(\0$]B7&-;L]Y$S9;0+913[5 MEW@9XO@TC23(T7@I3KI^#6_>A#?CK-*7&N FG?<:^KW'CS1=A!G?:G[*/BN, MLW A.BKH8S!@@\A-<9U!+S*3^1?QHV&M]=-]M3((_V>110Y(<'>7 MBI4*)*P4D >NX64D& "ST/,(F,W8R4)M&#\G6$209Q#XCQ\W82H*%[S CO,J M_5AAO:M_VBBN^MZ)@[;$+8^);6]OV-_2N$6[Q :.VSL%^:9KM59/] MT8>A\U_J$=.^P6] MP^"(B3"(:%8NMCNGN7Z)FZYL.YG(R^*$>YT?2 %980(0,J62,_'8M[5LVOKL MQ@M ]7<8+9.1< Z$EA%94=ZK>;$25/_0C@9B9US)]_DB#Q_"_.E&'%5KV%B MI[C--P3%..1$^T(D)F/X Z#]<#.-VUR+/:IE=[D2\"1LX&&X&V.P^=$)2(,- M2*(7/O>F"'7'JQ7EWM'3>)&LZ4WP>!7D8A-)O BCXK(TRR#77Z4RO/51B1S8 M^G\5=DCKY8E-,.MAH!'&=O*D4$"8!L)5D*8.WR+; .!J8MI@.JBCF;UJ71Q# M(-D4$>R(KFB:TB7S=YYE-,_F\?(L#&Z9RWE(,\O@U4N;,FY9:D,.6;V^!3M: MV3IA$ZCL=#=B5"4J8I,0]BT:]4.B)A -@;8Z!EEIU86?85R9(O*G<HQ=A0!V+4)'$9UC5A1E'XCBI-] M^2)L9.23$/%E>,<>7)J080E0=90P*=(%!FN03Q$+VIZQX/5+DBP_AU%DV0*Q MUJ2,#A::D,.$]3=@QPL;!VP"!UQO(X)T@H9OP<(>=)JHT1?!ZO !UJB+(_WI M,$5 @1U##VMG]-"E#"I6NI##2H_OP XL=B[8A!8;S8W@HKSK)3L@MT^MUYXV M5OH@5!.!^@->'8,L=.JBT!#^^#,75IL9S\JI\0_MJ7%8;$+2;SDS9J%_E DR MZ^\=9Y[,QJWATV5P:\U9,U[PC5B90>KJ2%T?CX3U@J5.(I3Z&A6QN&$]X]:7 M?K83;V []O-O_1D^YF%3BVT:YD]'=)-D85Z-=JG.:3<5[QPWI2J.=-Z4WANL M Z>45B G3BF$9^43DHK;55D\X!1D?Q5-I8UH*JV2E"R2]9JO[ HBL@_8.*Y M$"4R'O>"[LA[.'3)7I7KQ?_]5ARL62PIUV[.0#8AVW6!9@)O.P7R5R/ND\#S M#+@! LM@M?OMH3S3U;NM;]A(EV\Y<,.G3MA#-*78)."*M5.'4*M@:!76G :H M,4+-@*#QU4RL RT''1;UT0F_&BWZ:@9RNA<[H3QS"B.7YSO)C?5%%#\ER80I MT76EZTV4/%'J2Z<5!6&PDX=Z8VSZ\WOZI!?C>47E[C1ZF88+>I5$$<,'%\1N M ]V!*N9/,"1:1O3@W_!B9O<0_QWV##O[]:L*DC*DJ0J2D19GX/K*(S%:^YC M10^T3D%OAQ"[#GB1S*-$IIR0*;_V)$E7-,RW+-:>EL>&Z+ZZ;QISY(9M$D-W M8YP4YNC7&RF!X7N/D+ZPG9J5 O2YC#>Y8J1]DG(;&ZQ3%+([/1*4ZRCE47I2 M?>E9&-/3G*Y5UYCA*<;J!]443]NOZ7SAQ/V4NC\.^QU[,S/(*B7#(B6NC0AU MOJQ4P@,\7C="12:T;L'. &(S7TW4D>.BL4%M;.JB-T)=-0\M&VYEDXI5[)JQ M-N-#L =D([+IAJ8DXV4\HB6D 01NFN@:#6[JV^6 _-Z 3=7S@?>/8LE)<5+T MOM;%@77A6BQ&#;-L&\1>C0N!D0 ;7#=BP>]!=%,[=G]>Z:1C#SW=P!Y[L';# MC[&'GK^>)V,/]MZ/,/9@Z]1,"+R8D8>^?,0?>1@6&=!''BS=<3#R,#1&/:/D M] LKF4^:E^P]P$Y)-A[XD8WL?S-/$I&5XR/D( M_9KMIVJ*+QIKFHLM&DD(5 MN>.Z7DQZZD%+_,S4.S:@)R6X)P[RT8 Y5$JLOI(1PN)Y$:0%PFUC7BQ $C^ MY7XL[NGXYG[A3LMDN:9^%\3)NRC+[?1<@Q[*4W3&/XRF6? Y5%7 M&@]R338.3:BN!4'IK.-:1VY7@:U[$:0M M?RL_6F)PI]W'H&?9?J&IV>0?$Z" M,!67TLZS;+O>#9+3!?O&H_ A7#*^\:/=L=..K5VLA .W.VVJL?U])DXR%NXZ M3"]@+V;57^0II-%S[T)8%KHP_*2].R U(S0,*X[%,\\V0 ():#[H&) MQ?A=@8Y%%\W^9Q0R@&/%/Q=!(Z9W_/1"]V/%*D\GB1Y_>_?L3)#&8 MX7)N74I"A[/HA3VG\^4*OC^?6#Q?+D/^CR Z"K-%E&0\R\QO^2GWB]Q17 ;9 M1([1!IM>Q&O0[^)'[#:YZCZ.ZSWHGE5Y1==!&/.E\8=)+ IM@XBIE/PW\GBQ5,?AB99+M?R85<_)P^[%,T\'/:@USKHI+:]'63G5]&"D MM5.&H/(,TD31URDOF.>PV"N MM%I,N64DV#UZYH';"'^\, UD&EI05ME##,%@4C^#@"M+)U=A]L=)2NEIG%/V M@?E8K7*=79=MTS"\CE)V8MG'M:M M2>6V-0[@L].VN,R^XY8X*)0\T[0PCY^R8,'4L:8^8_!HO:2J@57R'\/W# M4_.2/1Y;YX^AW35 *)9 L6B@)8>Q"N4W %R'JQ?Z>X&?2^, M\,]Z!T7M#N33.$_#. L7H@OK:,6NT9Z[V^K;]KQ8J6O\/?Q8I:MS<]0KYEO6 M4;?)ULP?RYGDMX;&7\BKM.KU'_GG%&+L&87$0_'$\PFY: MO<<3!AS>/*R]E)ZU^AHJW.'T!0<+23/2MW#QWCY<7.=!FD\9,-Y/'##>2P/& M+;T+8[&'B(6-EW3#AE=AX_V7$#;>^]S[5%[K)/[OAODWCY>\=\V'6XX2OK&N M;\=S@"FTV_1TIB:^-L_\*TQ]/Y[60Y<7X6D,SX[_O@WSIZ*K2#X53[T>$$1B M!.)%=F#^68?G'B8QKZ:S8+M'(5GU-<48Z&F6;>G2U6EX.AM8 W]R&].VK'7? M/?$ G\(UATUFJ<49_SN(BTM%DZ+-0U9)2C:L5NZ9"OY\D:S72?PRSD_14@&O MC0Q@'%JK6&8+L24,(O8S"+3=%KW3LZN4=MS-M'AU=I7R^[V;61GQ[*JNU=WU MG\G^U3,/L48"N!R*&.6(JHX]IP,/?M/Z.4QFU#R=@.-?Y.3%Z)0?<[)B--+[ M.#E1>O8L)B5JODY!_"]W$F)\^H\XZ3 >_;V>9(!_S03W!5M:=]P;W!5O^ M5MYUX":_+QCJB[ME0__5Z+\W M(>Z+[.MZ'8S&[!=[&8Y\[$-K_7T6/6OC%_@3DK[<7KC?@6G$'KN?@"@,758[Y6Z MKI(H.DE2_M+]&*W$F+LAV88QW[H&DE_"NP'7IH^CMO3KILN3PWV.Q6AD<-E* M5Y//89.\9M1I"UQ']N<3EW]A!?/=Y:&M7H5X>13D='<0HJ. W=,+Y$AN[847 M(;[G;^='[+=WWGU2L/5I=Z/HSF_ M;C8T%?\Z"]>AW64,N"9=#G1W3/HWXJWX53P<^NYZ.O(8>-N!_7FZ&S&,S1JZ MF1CL;C5W#\@Z> S7V[7/V0295&Z'N/54=CK6W3+M>-#;%$">:?0_2SZ/'?T5 M)EU&_XY)_Z*_XE?Q,/IW/1TY^K<=L(C^8?Q"H[^*5&ZCOY[*3J-_R[3CZ&\* M("-&__ N#E?A@B%ZOE@DVS@/XSMQ5T=(LQOZF']@QO]0Q7$KX79$!@KCQ%8K M3Y&B)-0F(-[!5,VN?_WX<7[U.[DX(=>GOYR?GIP>SL]OR/SP\.+7\YO3\U_( MY<79Z>'I\;4G, G3@"4B*)"/T /"*W\R 78Q5G84Q/V3^5%]8H M"[8Y*RF(PT^E!TA^[*V25V17>Z8*KW#DXZ A!-F M@$R _XO589#=GT3)Y\QT22A 1,4)J0@N.S1>(?-$;LF",3(%L\.+\Z/C\^OC M(\+^=DT^5J&_\TL%#S30S MJ)2!X@0\O EN(^4R"VDA%=?*0KCL:EA&YE.EVX)!A4@]WX@GOE&A M65]J\,OJ50EW45@#<'G]3Y):3L(XB!=A$%TF62@FB< IQBBJ3C4:4>R48_02 M/?7H+%JE(+4B52KZ,#^;GQ\>D^O_.#Z^\3H!F<&C2T10Z&D2DE*%-C'!@3LF MFUE'K3BL\6B;\EY SU$(O% 'L0#AO5E N9 M22A*D3 F&ZP4K.$C+4J"3RZZGU"Y*G2$)"@"OGB:N[F62WE_C#F MXH_D4U'.FY1JAH&7IS?S,W)]?,DGGF,OT-9%A#13/1>3C6 X(!,-'U9EQ= M&)K2O&0>F&U@ACECE6LF]62//"^1>9ZGX>TVK\;L+X.4QKFO)+(ACC59( 1Q MAAIWIS+*3?6!$-^"]2&(^.U)+P$@YHU,O2""=_Q>5[7#D_+DQGK!Y/W+@HGQ MV+9^,.D>AH8&D^]M8)(G>1#U LCW?0'R_5>S&VZ5/*>NDA5FOG>#F>^G;)1M M;S/Z]RUK'1P_\%E\?A_E8ZAJ4KC,$3O"U)#36D$0!&%[&S_@H@W MA+]BG1WVTI>.CJ&>NV0! :/#%[F4A#13(,G5OG^-M=Z@XHVXXI;A%XLE<\-N M()JFW?'=].G,M#[<4%P?B<^PUXH;O'$2B\_LUHVKA+O1V,-%Y*;:-G%(A0\# MAO+@KB[0^>&$-C8K"J22$L+XM7I 6[4FIL!6#,AD MC!R9?I5 TQ_S9D)3>3U1\+<,FOQQ0AC;C8%*Z=GUKQ^NC__WK\?G-^3X-[ZW MPDO"@';Y 9%A((YV+Q\83-,1R#1K:"ANH _V3*'!&S?DL9L=5 EWJ>/?W*"I MLHTD@LX'*L3,%/)A#K#;]=+?NF J;QYRPKT!P>2/LV$GF]L(E-*JH2>_K@,P MUCEDR !V-+]*#C1H,/TQ^2V?=)OY-$4-',+M_P+[Y8 MG<;+\"%<;H/HKV%^?T4CX5]V'VYNDN.8_2Q/VH9E3RTMNEMK0:%]3]]QZ&]O MW!P&;'7.ZN\XAHNWGK5C^T*L$Q*&8;4=&BRU=4/$4-!/&"HT2QNT94VT1YR, MUOKAB,+@)0URR9EXS'?X[E]X-06MKULSWP!+&:0R .ZX1HZC10QJ6SU!Q!

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end